QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) | |
(Address of principal executive offices) |
(Zip Code) |
☒ |
Accelerated filer |
☐ | ||||
Non-accelerated filer |
☐ |
Smaller reporting company |
||||
Emerging growth company |
Title of Each Class |
Trading Symbol |
Name of each exchange on which registered | ||
Page |
||||||
Item 1. |
3 |
|||||
3 |
||||||
4 |
||||||
5 |
||||||
6 |
||||||
7 |
||||||
8 |
||||||
Item 2. |
66 |
|||||
Item 3. |
130 |
|||||
Item 4. |
130 |
|||||
Item 1. |
131 |
|||||
Item 1A. |
131 |
|||||
Item 6. |
131 |
|||||
132 |
Item 1. |
Financial Statements |
March 31, 2021 |
December 31, 2020 |
|||||||
(Unaudited) |
||||||||
Assets |
||||||||
Investments: |
||||||||
Fixed maturity securities available-for-sale, at fair value (amortized cost of $ |
$ | $ | ||||||
Equity securities, at fair value |
||||||||
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $ |
||||||||
Less: Allowance for credit losses |
( |
) | ( |
) | ||||
Commercial mortgage loans, net |
||||||||
Policy loans |
||||||||
Other invested assets |
||||||||
Total investments |
||||||||
Cash, cash equivalents and restricted cash |
||||||||
Accrued investment income |
||||||||
Deferred acquisition costs |
||||||||
Intangible assets |
||||||||
Reinsurance recoverable |
||||||||
Less: Allowance for credit losses |
( |
) | ( |
) | ||||
Reinsurance recoverable, net |
||||||||
Other assets |
||||||||
Deferred tax asset |
||||||||
Separate account assets |
||||||||
Assets related to discontinued operations |
||||||||
Total assets |
$ | $ | ||||||
Liabilities and equity |
||||||||
Liabilities: |
||||||||
Future policy benefits |
$ | $ | ||||||
Policyholder account balances |
||||||||
Liability for policy and contract claims |
||||||||
Unearned premiums |
||||||||
Other liabilities |
||||||||
Long-term borrowings |
||||||||
Separate account liabilities |
||||||||
Liabilities related to discontinued operations |
||||||||
Total liabilities |
||||||||
Commitments and contingencies |
||||||||
Equity: |
||||||||
Class A common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated other comprehensive income (loss) |
||||||||
Retained earnings |
||||||||
Treasury stock, at cost ( |
( |
) | ( |
) | ||||
Total Genworth Financial, Inc.’s stockholders’ equity |
||||||||
Noncontrolling interests |
||||||||
Total equity |
||||||||
Total liabilities and equity |
$ | $ | ||||||
Three months ended |
||||||||
March 31, |
||||||||
2021 |
2020 |
|||||||
Revenues: |
||||||||
Premiums |
$ | $ | ||||||
Net investment income |
||||||||
Net investment gains (losses) |
( |
) | ||||||
Policy fees and other income |
||||||||
|
|
|
|
|||||
Total revenues |
||||||||
|
|
|
|
|||||
Benefits and expenses: |
||||||||
Benefits and other changes in policy reserves |
||||||||
Interest credited |
||||||||
Acquisition and operating expenses, net of deferrals |
||||||||
Amortization of deferred acquisition costs and intangibles |
||||||||
Interest expense |
||||||||
|
|
|
|
|||||
Total benefits and expenses |
||||||||
|
|
|
|
|||||
Income (loss) from continuing operations before income taxes |
( |
) | ||||||
Provision (benefit) for income taxes |
( |
) | ||||||
|
|
|
|
|||||
Income (loss) from continuing operations |
( |
) | ||||||
Income (loss) from discontinued operations, net of taxes |
( |
) | ||||||
|
|
|
|
|||||
Net income (loss) |
( |
) | ||||||
Less: net income from continuing operations attributable to noncontrolling interests |
||||||||
Less: net income (loss) from discontinued operations attributable to noncontrolling interests |
( |
) | ||||||
|
|
|
|
|||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ( |
) | ||||
|
|
|
|
|||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ( |
) | ||||
Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common common stockholders |
( |
) | ||||||
|
|
|
|
|||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ( |
) | ||||
|
|
|
|
|||||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||
Basic |
$ | $ | ( |
) | ||||
|
|
|
|
|||||
Diluted |
$ | $ | ( |
) | ||||
|
|
|
|
|||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||
Basic |
$ | $ | ( |
) | ||||
|
|
|
|
|||||
Diluted |
$ | $ | ( |
) | ||||
|
|
|
|
|||||
Weighted-average common shares outstanding: |
||||||||
Basic |
||||||||
|
|
|
|
|||||
Diluted |
||||||||
|
|
|
|
Three months ended |
||||||||
March 31, |
||||||||
2021 |
2020 |
|||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Other comprehensive income (loss), net of taxes: |
||||||||
Net unrealized gains (losses) on securities without an allowance for credit losses |
( |
) | ( |
) | ||||
Net unrealized gains (losses) on securities with an allowance for credit losses |
||||||||
Derivatives qualifying as hedges |
( |
) | ||||||
Foreign currency translation and other adjustments |
( |
) | ||||||
|
|
|
|
|||||
Total other comprehensive income (loss) |
( |
) | ||||||
|
|
|
|
|||||
Total comprehensive income (loss) |
( |
) | ||||||
Less: comprehensive income (loss) attributable to noncontrolling interests |
( |
) | ||||||
|
|
|
|
|||||
Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | ( |
) | $ | ||||
|
|
|
|
Three months ended March 31, 2021 |
||||||||||||||||||||||||||||||||
Total |
||||||||||||||||||||||||||||||||
Genworth |
||||||||||||||||||||||||||||||||
Accumulated |
Financial, |
|||||||||||||||||||||||||||||||
Additional |
other |
Treasury |
Inc.’s |
|||||||||||||||||||||||||||||
Common |
paid-in |
comprehensive |
Retained |
stock, at |
stockholders’ |
Noncontrolling |
Total |
|||||||||||||||||||||||||
stock |
capital |
income (loss) |
earnings |
cost |
equity |
interests |
equity |
|||||||||||||||||||||||||
Balances as of December 31, 2020 |
$ | $ | $ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
Sale of business that included noncontrolling interests |
( |
) | ( |
) | ||||||||||||||||||||||||||||
Comprehensive income (loss): |
||||||||||||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of taxes |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total comprehensive income (loss) |
( |
) | ( |
) | ||||||||||||||||||||||||||||
Stock-based compensation expense and exercises and other |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balances as of March 31, 2021 |
$ | $ | $ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Three months ended March 31, 2020 |
||||||||||||||||||||||||||||||||
Total |
||||||||||||||||||||||||||||||||
Genworth |
||||||||||||||||||||||||||||||||
Accumulated |
Financial, |
|||||||||||||||||||||||||||||||
Additional |
other |
Treasury |
Inc.’s |
|||||||||||||||||||||||||||||
Common |
paid-in |
comprehensive |
Retained |
stock, at |
stockholders’ |
Noncontrolling |
Total |
|||||||||||||||||||||||||
stock |
capital |
income (loss) |
earnings |
cost |
equity |
interests |
equity |
|||||||||||||||||||||||||
Balances as of December 31, 2019 |
$ | $ | $ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
Cumulative effect of change in accounting, net of taxes |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
Comprehensive income (loss): |
||||||||||||||||||||||||||||||||
Net loss |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||
Other comprehensive income (loss),net of taxes |
( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total comprehensive income (loss) |
( |
) | ||||||||||||||||||||||||||||||
Dividends to noncontrolling interests |
( |
) | ( |
) | ||||||||||||||||||||||||||||
Stock-based compensation expense and exercises and other |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balances as of March 31, 2020 |
$ | $ | $ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
||||||||
March 31, |
||||||||
2021 |
2020 |
|||||||
Cash flows from (used by) operating activities: |
||||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Less (income) loss from discontinued operations, net of taxes |
( |
) | ||||||
Adjustments to reconcile net income (loss) to net cash from (used by) operating activities: |
||||||||
Amortization of fixed maturity securities discounts and premiums |
( |
) | ( |
) | ||||
Net investment (gains) losses |
( |
) | ||||||
Charges assessed to policyholders |
( |
) | ( |
) | ||||
Acquisition costs deferred |
( |
) | ( |
) | ||||
Amortization of deferred acquisition costs and intangibles |
||||||||
Deferred income taxes |
( |
) | ||||||
Derivative instruments, limited partnerships and other |
( |
) | ||||||
Stock-based compensation expense |
||||||||
Change in certain assets and liabilities: |
||||||||
Accrued investment income and other assets |
( |
) | ( |
) | ||||
Insurance reserves |
||||||||
Current tax liabilities |
( |
) | ||||||
Other liabilities, policy and contract claims and other policy-related balances |
( |
) | ||||||
Cash used by operating activities—discontinued operations |
( |
) | ( |
) | ||||
Net cash from (used by) operating activities |
( |
) | ||||||
Cash flows from (used by) investing activities: |
||||||||
Proceeds from maturities and repayments of investments: |
||||||||
Fixed maturity securities |
||||||||
Commercial mortgage loans |
||||||||
Other invested assets |
||||||||
Proceeds from sales of investments: |
||||||||
Fixed maturity and equity securities |
||||||||
Purchases and originations of investments: |
||||||||
Fixed maturity and equity securities |
( |
) | ( |
) | ||||
Commercial mortgage loans |
( |
) | ( |
) | ||||
Other invested assets |
( |
) | ( |
) | ||||
Short-term investments, net |
( |
) | ||||||
Policy loans, net |
||||||||
Proceeds from sale of business, net of cash transferred |
||||||||
Cash from (used by) investing activities—discontinued operations |
( |
) | ||||||
Net cash from (used by) investing activities |
( |
) | ||||||
Cash flows used by financing activities: |
||||||||
Deposits to universal life and investment contracts |
||||||||
Withdrawals from universal life and investment contracts |
( |
) | ( |
) | ||||
Redemption of non-recourse funding obligations |
( |
) | ||||||
Repayment and repurchase of long-term debt |
( |
) | ( |
) | ||||
Other, net |
||||||||
Cash used by financing activities—discontinued operations |
( |
) | ||||||
Net cash used by financing activities |
( |
) | ( |
) | ||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $( |
( |
) | ||||||
Net change in cash, cash equivalents and restricted cash |
( |
) | ( |
) | ||||
Cash, cash equivalents and restricted cash at beginning of period |
||||||||
Cash, cash equivalents and restricted cash at end of period |
||||||||
Less cash, cash equivalents and restricted cash of discontinued operations at end of period |
||||||||
Cash, cash equivalents and restricted cash of continuing operations at end of period |
$ | $ | ||||||
• | U.S. Mortgage Insurance. |
• | U.S. Life Insurance. |
• | Runoff. |
• | As of March 31, 2021, Genworth Holdings has outstanding $ |
• | As part of the settlement agreement reached in July 2020 regarding the case titled AXA S.A. v. Genworth Financial International Holdings, LLC et al., |
• | Genworth Holdings received in the first quarter of 2021 intercompany cash tax payments generated primarily from taxable income on investment gains and is expecting additional intercompany cash tax payments in future periods. |
• | Until the secured promissory note to AXA is paid, annual dividends above $ million from our U.S. mortgage insurance subsidiary are subject to mandatory prepayment conditions. |
• | assumptions will no longer be locked-in at contract inception and all cash flow assumptions used to estimate the liability for future policy benefits (except the discount rate) will be reviewed at least annually in the same period each year or more frequently if actual experience indicates a change is required. Changes will be recorded in net income (loss) using a retrospective approach with a cumulative catch-up adjustment by recalculating the net premium ratio (which will be capped at 100%) using actual historical and updated future cash flow assumptions; |
• | the discount rate used to determine the liability for future policy benefits will be a current upper-medium grade (low credit risk) fixed-income instrument yield, which is generally interpreted to mean a single-A rated bond rate for the same duration, and is required to be reviewed quarterly, with changes in the discount rate recorded in other comprehensive income (loss); |
• | the provision for adverse deviation and the premium deficiency test will be eliminated; |
• | market risk benefits associated with deposit-type contracts will be measured at fair value with changes related to instrument-specific credit risk recorded in other comprehensive income (loss) and remaining changes recorded in net income (loss); |
• | the amortization method for DAC will generally be on a straight-line basis over the expected contract term; and |
• | disclosures will be greatly expanded to include significant assumptions and product liability rollforwards. |
Three months ended |
||||||||
March 31, |
||||||||
(Amounts in millions, except per share amounts) |
2021 |
2020 |
||||||
Weighted-average shares used in basic earnings per share calculations |
||||||||
Potentially dilutive securities: |
||||||||
Stock options, restricted stock units and stock appreciation rights |
||||||||
Weighted-average shares used in diluted earnings (loss) per share calculations (1) |
||||||||
Income (loss) from continuing operations: |
||||||||
Income (loss) from continuing operations |
$ | $ | ( |
) | ||||
Less: net income from continuing operations attributable to noncontrolling interests |
||||||||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ( |
) | ||||
Basic per share |
$ | $ | ( |
) | ||||
Diluted per share |
$ | $ | ( |
) | ||||
Income (loss) from discontinued operations: |
||||||||
Income (loss) from discontinued operations, net of taxes |
$ | $ | ( |
) | ||||
Less: net income (loss) from discontinued operations attributable to noncontrolling interests |
( |
) | ||||||
Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ( |
) | ||||
Basic per share |
$ | $ | ( |
) | ||||
Diluted per share |
$ | $ | ( |
) | ||||
Net income (loss): |
||||||||
Income (loss) from continuing operations |
$ | $ | ( |
) | ||||
Income (loss) from discontinued operations, net of taxes |
( |
) | ||||||
Net income (loss) |
( |
) | ||||||
Less: net income (loss) attributable to noncontrolling interests |
( |
) | ||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ( |
) | ||||
Basic per share |
$ | $ | ( |
) | ||||
Diluted per share (2) |
$ | $ | ( |
) | ||||
(1) |
Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended March 31, 2020, we were required to use basic weighted-average common shares outstanding as the inclusion of shares for stock options, restricted stock units and stock appreciation rights of |
(2) |
May not total due to whole number calculation. |
Three months ended |
||||||||
March 31, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Fixed maturity securities—taxable |
$ | $ | ||||||
Fixed maturity securities—non-taxable |
||||||||
Equity securities |
||||||||
Commercial mortgage loans |
||||||||
Policy loans |
||||||||
Other invested assets |
||||||||
Cash, cash equivalents, restricted cash and short-term investments |
||||||||
Gross investment income before expenses and fees |
||||||||
Expenses and fees |
( |
) | ( |
) | ||||
Net investment income |
$ | $ | ||||||
Three months ended |
||||||||
March 31, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Available-for-sale fixed maturity securities: |
||||||||
Realized gains |
$ | $ | ||||||
Realized losses |
( |
) | ||||||
Net realized gains (losses) on available-for-sale fixed maturity securities |
||||||||
Net change in allowance for credit losses on available-for-sale fixed maturity securities |
( |
) | ||||||
Write-down of available-for-sale fixed maturity securities (1) |
( |
) | ||||||
Net realized gains (losses) on equity securities sold |
( |
) | ||||||
Net unrealized gains (losses) on equity securities still held |
( |
) | ( |
) | ||||
Limited partnerships |
( |
) | ||||||
Commercial mortgage loans |
( |
) | ||||||
Derivative instruments (2) |
( |
) | ||||||
Other |
( |
) | ||||||
Net investment gains (losses) |
$ | $ | ( |
) | ||||
(1) |
Represents write-down of securities deemed uncollectible or that we intend to sell or will be required to sell prior to recovery of the amortized cost basis. |
(2) |
See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses). |
Increase from |
Increase |
|||||||||||||||||||||||||||||||
securities |
(decrease) |
Decrease |
||||||||||||||||||||||||||||||
without |
from securities |
due to change |
||||||||||||||||||||||||||||||
allowance in |
with allowance |
in intent or |
||||||||||||||||||||||||||||||
Beginning |
previous |
in previous |
Securities |
requirement |
Ending |
|||||||||||||||||||||||||||
(Amounts in millions) |
balance |
periods |
periods |
sold |
to sell |
Write-offs |
Recoveries |
balance |
||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||
Non-U.S. corporate |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ||||||||||||||||||||||||||||||
Total available-for-sale fixed maturity securities |
$ | $ | $ | $ | $ | $ | ( |
) | $ | $ | ||||||||||||||||||||||
(Amounts in millions) |
March 31, 2021 |
December 31, 2020 |
||||||
Net unrealized gains (losses) on fixed maturity securities without an allowance for credit losses (1) |
$ | $ | ||||||
Net unrealized gains (losses) on fixed maturity securities with an allowance for credit losses (1) |
( |
) | ( |
) | ||||
Adjustments to DAC, present value of future profits, sales inducements, benefit reserves and policyholder contract balances |
( |
) | ( |
) | ||||
Income taxes, net |
( |
) | ( |
) | ||||
Net unrealized investment gains (losses) |
||||||||
Less: net unrealized investment gains (losses) attributable to noncontrolling interests |
||||||||
Net unrealized investment gains (losses) attributable to Genworth Financial, Inc. |
$ | $ | ||||||
(1) |
Excludes foreign exchange. |
(Amounts in millions) |
2021 |
2020 |
||||||
Beginning balance |
$ | $ | ||||||
Unrealized gains (losses) arising during the period: |
||||||||
Unrealized gains (losses) on fixed maturity securities |
( |
) | ( |
) | ||||
Adjustment to DAC |
( |
) | ||||||
Adjustment to present value of future profits |
( |
) | ||||||
Adjustment to sales inducements |
||||||||
Adjustment to benefit reserves and policyholder contract balances |
||||||||
Provision for income taxes |
||||||||
Change in unrealized gains (losses) on investment securities |
( |
) | ( |
) | ||||
Reclassification adjustments to net investment (gains) losses, net of taxes of $ |
( |
) | ( |
) | ||||
Change in net unrealized investment gains (losses) |
( |
) | ( |
) | ||||
Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests |
( |
) | ( |
) | ||||
Ending balance |
$ | $ | ||||||
Amortized |
Gross |
Gross |
Allowance |
|||||||||||||||||
cost or |
unrealized |
unrealized |
for credit |
Fair |
||||||||||||||||
(Amounts in millions) |
cost |
gains |
losses |
losses |
value |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | ( |
) | $ | $ | |||||||||||||
State and political subdivisions |
( |
) | ||||||||||||||||||
Non-U.S. government |
( |
) | ||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
( |
) | ||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||
Finance and insurance |
( |
) | ||||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||
Technology and communications |
( |
) | ||||||||||||||||||
Industrial |
( |
) | ||||||||||||||||||
Capital goods |
( |
) | ||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||
Other |
( |
) | ||||||||||||||||||
Total U.S. corporate |
( |
) | ||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
( |
) | ||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||
Technology and communications |
( |
) | ||||||||||||||||||
Industrial |
( |
) | ||||||||||||||||||
Capital goods |
( |
) | ||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||
Other |
( |
) | ||||||||||||||||||
Total non-U.S. corporate |
( |
) | ( |
) | ||||||||||||||||
Residential mortgage-backed |
( |
) | ||||||||||||||||||
Commercial mortgage-backed |
( |
) | ||||||||||||||||||
Other asset-backed |
( |
) | ||||||||||||||||||
Total available-for-sale fixed maturity securities |
$ | $ | $ | ( |
) | $ | ( |
) | $ | |||||||||||
Amortized |
Gross |
Gross |
Allowance |
|||||||||||||||||
cost or |
unrealized |
unrealized |
for credit |
Fair |
||||||||||||||||
(Amounts in millions) |
cost |
gains |
losses |
losses |
value |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | $ | $ | |||||||||||||||
State and political subdivisions |
( |
) | ||||||||||||||||||
Non-U.S. government |
( |
) | ||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
( |
) | ||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||
Finance and insurance |
( |
) | ||||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
||||||||||||||||||||
Consumer—cyclical |
||||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||
Other |
||||||||||||||||||||
Total U.S. corporate |
( |
) | ||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
||||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
( |
) | ||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||
Other |
||||||||||||||||||||
Total non-U.S. corporate |
( |
) | ( |
) | ||||||||||||||||
Residential mortgage-backed |
||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ( |
) | ||||||||||||||||
Other asset-backed |
( |
) | ||||||||||||||||||
Total available-for-sale fixed maturity securities |
$ | $ | $ | ( |
) | $ | ( |
) | $ | |||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
Gross |
Gross |
Gross |
||||||||||||||||||||||||||||||||||
Fair |
unrealized |
Number of |
Fair |
unrealized |
Number of |
Fair |
unrealized |
Number of |
||||||||||||||||||||||||||||
(Dollar amounts in millions) |
value |
losses |
securities |
value |
losses |
securities |
value |
losses |
securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||
State and political subdivisions |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Non-U.S. government |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Non-U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Residential mortgage-backed |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
% Below cost: |
||||||||||||||||||||||||||||||||||||
<20% Below cost |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
20%-50% Below cost |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Investment grade |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Below investment grade |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
Gross |
Gross |
Gross |
||||||||||||||||||||||||||||||||||
Fair |
unrealized |
Number of |
Fair |
unrealized |
Number of |
Fair |
unrealized |
Number of |
||||||||||||||||||||||||||||
(Dollar amounts in millions) |
value |
losses |
securities |
value |
losses |
securities |
value |
losses |
securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Utilities |
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | — | — | — | ( |
) | |||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Subtotal, U.S. corporate securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Subtotal, non-U.S. corporate securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for corporate securities in an unrealized loss position |
$ | $ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
||||||||||||||||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
Gross |
Gross |
Gross |
||||||||||||||||||||||||||||||||||
Fair |
unrealized |
Number of |
Fair |
unrealized |
Number of |
Fair |
unrealized |
Number of |
||||||||||||||||||||||||||||
(Dollar amounts in millions) |
value |
losses |
securities |
value |
losses |
securities |
value |
losses |
securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||
State and political subdivisions |
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||
Non-U.S. government |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Non-U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
% Below cost: |
||||||||||||||||||||||||||||||||||||
<20% Below cost |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
20%-50% Below cost |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Investment grade |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Below investment grade |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
Gross |
Gross |
Gross |
||||||||||||||||||||||||||||||||||
Fair |
unrealized |
Number of |
Fair |
unrealized |
Number of |
Fair |
unrealized |
Number of |
||||||||||||||||||||||||||||
(Dollar amounts in millions) |
value |
losses |
securities |
value |
losses |
securities |
value |
losses |
securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Utilities |
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Subtotal, U.S. corporate securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Subtotal, non-U.S. corporate securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for corporate securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Amortized |
||||||||
cost or |
Fair |
|||||||
(Amounts in millions) |
cost |
value |
||||||
Due one year or less |
$ | $ | ||||||
Due after one year through five years |
||||||||
Due after five years through ten years |
||||||||
Due after ten years |
||||||||
Subtotal |
||||||||
Residential mortgage-backed |
||||||||
Commercial mortgage-backed |
||||||||
Other asset-backed |
||||||||
Total |
$ | $ | ||||||
March 31, 2021 |
December 31, 2020 |
|||||||||||||||
Carrying |
% of |
Carrying |
% of |
|||||||||||||
(Amounts in millions) |
value |
total |
value |
total |
||||||||||||
Property type: |
||||||||||||||||
Retail |
$ | % | $ | % | ||||||||||||
Industrial |
||||||||||||||||
Office |
||||||||||||||||
Apartments |
||||||||||||||||
Mixed use |
||||||||||||||||
Other |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Subtotal |
% | % | ||||||||||||||
|
|
|
|
|||||||||||||
Allowance for credit losses |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|||||||||||||
Total |
$ | $ | ||||||||||||||
|
|
|
|
March 31, 2021 |
December 31, 2020 |
|||||||||||||||
Carrying |
% of |
Carrying |
% of |
|||||||||||||
(Amounts in millions) |
value |
total |
value |
total |
||||||||||||
Geographic region: |
||||||||||||||||
South Atlantic |
$ | % | $ | % | ||||||||||||
Pacific |
||||||||||||||||
Middle Atlantic |
||||||||||||||||
Mountain |
||||||||||||||||
West North Central |
||||||||||||||||
East North Central |
||||||||||||||||
West South Central |
||||||||||||||||
New England |
||||||||||||||||
East South Central |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Subtotal |
% | % | ||||||||||||||
|
|
|
|
|||||||||||||
Allowance for credit losses |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|||||||||||||
Total |
$ | $ | ||||||||||||||
|
|
|
|
Three months ended |
||||||||
March 31, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Allowance for credit losses: |
||||||||
Beginning balance |
$ | $ | ||||||
Cumulative effect of change in accounting |
||||||||
Provision |
||||||||
Write-offs |
||||||||
Recoveries |
||||||||
|
|
|
|
|||||
Ending balance |
$ | $ | ||||||
|
|
|
|
2016 and |
||||||||||||||||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2019 |
2018 |
2017 |
prior |
Total |
|||||||||||||||||||||
Debt-to-value: |
||||||||||||||||||||||||||||
0% - 50% |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
51% - 60% |
||||||||||||||||||||||||||||
61% - 75% |
||||||||||||||||||||||||||||
76% - 100% |
||||||||||||||||||||||||||||
Greater than 100% |
||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Debt service coverage ratio: |
||||||||||||||||||||||||||||
Less than 1.00 |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
1.00 - 1.25 |
||||||||||||||||||||||||||||
1.26 - 1.50 |
||||||||||||||||||||||||||||
1.51 - 2.00 |
||||||||||||||||||||||||||||
Greater than 2.00 |
||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2021 |
||||||||||||||||||||||||
Greater |
||||||||||||||||||||||||
(Amounts in millions) |
0% - 50% |
51% - 60% |
61% - 75% |
76% - 100% |
than 100% |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Office |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Weighted-average debt service coverage ratio |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2020 |
||||||||||||||||||||||||
Greater |
||||||||||||||||||||||||
(Amounts in millions) |
0% - 50% |
51% - 60% |
61% - 75% |
76% - 100% |
than 100% |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Office |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Weighted-average debt service coverage ratio |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2021 |
||||||||||||||||||||||||
Greater |
||||||||||||||||||||||||
(Amounts in millions) |
Less than 1.00 |
1.00 - 1.25 |
1.26 - 1.50 |
1.51 - 2.00 |
than 2.00 |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Office |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
Weighted-average debt-to-value |
% | % | % | % | % | % | ||||||||||||||||||
December 31, 2020 |
||||||||||||||||||||||||
Greater |
||||||||||||||||||||||||
(Amounts in millions) |
Less than 1.00 |
1.00 - 1.25 |
1.26 - 1.50 |
1.51 - 2.00 |
than 2.00 |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Office |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
Weighted-average debt-to-value |
% | % | % | % | % | % | ||||||||||||||||||
Derivative assets |
Derivative liabilities |
|||||||||||||||||||||
Balance sheet classification |
Fair value |
Balance sheet classification |
Fair value |
|||||||||||||||||||
March 31, 2021 |
December 31, 2020 |
March 31, 2021 |
December 31, 2020 |
|||||||||||||||||||
(Amounts in millions) | ||||||||||||||||||||||
Derivatives designated as hedges |
||||||||||||||||||||||
Cash flow hedges: |
||||||||||||||||||||||
Interest rate swaps |
Other invested assets | $ | $ | Other liabilities | $ | $ | ||||||||||||||||
Foreign currency swaps |
Other invested assets | Other liabilities | ||||||||||||||||||||
Total cash flow hedges |
||||||||||||||||||||||
Total derivatives designated as hedges |
||||||||||||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||||
Equity index options |
Other invested assets | Other liabilities | ||||||||||||||||||||
Financial futures |
Other invested assets | Other liabilities | ||||||||||||||||||||
Other foreign currency contracts |
Other invested assets | Other liabilities | ||||||||||||||||||||
GMWB embedded derivatives |
Reinsurance recoverable (1) |
Policyholder account balances (2) |
|
|||||||||||||||||||
Fixed index annuity embedded derivatives |
Other assets | Policyholder account balances (3) |
|
|||||||||||||||||||
Indexed universal life embedded derivatives |
Reinsurance recoverable |
Policyholder account balances (4) |
|
|||||||||||||||||||
Total derivatives not designated as hedges |
||||||||||||||||||||||
Total derivatives |
$ | $ | $ | $ | ||||||||||||||||||
(1) |
Represents embedded derivatives associated with the reinsured portion of our guaranteed minimum withdrawal benefits (“GMWB”) liabilities. |
(2) |
Represents the embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
(3) |
Represents the embedded derivatives associated with our fixed index annuity liabilities. |
(4) |
Represents the embedded derivatives associated with our indexed universal life liabilities. |
December 31, |
Maturities/ |
March 31, |
||||||||||||||||||
(Notional in millions) |
Measurement |
2020 |
Additions |
terminations |
2021 |
|||||||||||||||
Derivatives designated as hedges |
||||||||||||||||||||
Cash flow hedges: |
||||||||||||||||||||
Interest rate swaps |
Notional | $ | $ | $ | ( |
) | $ | |||||||||||||
Foreign currency swaps |
Notional | |||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total cash flow hedges |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives designated as hedges |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||
Interest rate swaps |
Notional | |||||||||||||||||||
Equity index options |
Notional | ( |
) | |||||||||||||||||
Financial futures |
Notional | ( |
) | |||||||||||||||||
Other foreign currency contracts |
Notional | ( |
) | |||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives not designated as hedges |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives |
$ | $ | $ | ( |
) | $ | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
December 31, |
Maturities/ |
March 31, |
||||||||||||||||||
(Number of policies) |
Measurement |
2020 |
Additions |
terminations |
2021 |
|||||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||
GMWB embedded derivatives |
Policies | ( |
) | |||||||||||||||||
Fixed index annuity embedded derivatives |
Policies | ( |
) | |||||||||||||||||
Indexed universal life embedded derivatives |
Policies | ( |
) |
Gain (loss) |
||||||||||||||||||||
reclassified into |
Classification of gain |
Gain (loss) |
Classification of gain |
|||||||||||||||||
Gain (loss) |
net income (loss) |
(loss) reclassified into |
recognized in |
(loss) recognized in |
||||||||||||||||
(Amounts in millions) |
recognized in OCI |
from OCI |
net income (loss) |
net income (loss) |
net income (loss) |
|||||||||||||||
Interest rate swaps hedging assets |
$ | ( |
) | $ | Net investment income |
|
$ | Net investment gains (losses) |
| |||||||||||
Interest rate swaps hedging liabilities |
Interest expense | Net investment gains (losses) |
| |||||||||||||||||
Foreign currency swaps |
( |
) | Net investment income |
|
Net investment gains (losses) |
| ||||||||||||||
|
|
|
|
|
|
|||||||||||||||
Total |
$ | ( |
) | $ | $ | |||||||||||||||
|
|
|
|
|
|
Gain (loss) |
||||||||||||||||||||
reclassified into |
Classification of gain |
Gain (loss) |
Classification of gain |
|||||||||||||||||
Gain (loss) |
net income (loss) |
(loss) reclassified into |
recognized in |
(loss) recognized in |
||||||||||||||||
(Amounts in millions) |
recognized in OCI |
from OCI |
net income (loss) |
net income (loss) |
net income (loss) |
|||||||||||||||
Interest rate swaps hedging assets |
$ | $ | Net investment income |
|
$ | Net investment gains (losses) |
| |||||||||||||
Interest rate swaps hedging assets |
Net investment gains (losses) |
|
Net investment gains (losses) |
| ||||||||||||||||
Interest rate swaps hedging liabilities |
( |
) | Interest expense | Net investment gains (losses) |
| |||||||||||||||
Foreign currency swaps |
Net investment income |
|
Net investment gains (losses) |
| ||||||||||||||||
|
|
|
|
|
|
|||||||||||||||
Total |
$ | $ | $ | |||||||||||||||||
|
|
|
|
|
|
Three months ended |
||||||||
March 31, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Derivatives qualifying as effective accounting hedges as of January 1 |
$ | $ | ||||||
Current period increases (decreases) in fair value, net of deferred taxes of $ |
( |
) | ||||||
Reclassification to net (income) loss, net of deferred taxes of $ |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Derivatives qualifying as effective accounting hedges as of March 31 |
$ | $ | ||||||
|
|
|
|
Three months ended March 31, |
Classification of gain (loss) recognized | |||||||||
(Amounts in millions) |
2021 |
2020 |
in net income (loss) | |||||||
Interest rate swaps |
$ | $ | ( |
) | Net investment gains (losses) | |||||
Equity index options |
( |
) | Net investment gains (losses) | |||||||
Financial futures |
( |
) | Net investment gains (losses) | |||||||
Other foreign currency contracts |
Net investment gains (losses) | |||||||||
GMWB embedded derivatives |
( |
) | Net investment gains (losses) | |||||||
Fixed index annuity embedded derivatives |
( |
) | Net investment gains (losses) | |||||||
Indexed universal life embedded derivatives |
Net investment gains (losses) | |||||||||
Total derivatives not designated as hedges |
$ | $ | ( |
) | ||||||
March 31, 2021 |
December 31, 2020 |
|||||||||||||||||||||||
Derivative |
Derivative |
Net |
Derivative |
Derivative |
Net |
|||||||||||||||||||
(Amounts in millions) |
assets (1) |
liabilities (1) |
derivatives |
assets (1) |
liabilities (1) |
derivatives |
||||||||||||||||||
Amounts presented in the balance sheet: |
||||||||||||||||||||||||
Gross amounts recognized |
$ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||
Gross amounts offset in the balance sheet |
||||||||||||||||||||||||
Net amounts presented in the balance sheet |
( |
) | ||||||||||||||||||||||
Gross amounts not offset in the balance sheet: |
||||||||||||||||||||||||
Financial instruments (2) |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Collateral received |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Collateral pledged |
( |
) | ( |
) | ||||||||||||||||||||
Over collateralization |
( |
) | ( |
) | ||||||||||||||||||||
Net amount |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
(1) |
Does not include amounts related to embedded derivatives as of March 31, 2021 and December 31, 2020. |
(2) |
Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty. |
• | Third-party pricing services: |
(Amounts in millions) |
Fair value |
Primary methodologies |
Significant inputs | |||||
U.S. government, agencies and government-sponsored enterprises |
$ | |
||||||
State and political subdivisions |
$ | |||||||
Non-U.S. government |
$ | |||||||
U.S. corporate |
$ | |||||||
Non-U.S. corporate |
$ | |||||||
Residential mortgage-backed |
$ | |||||||
Commercial mortgage-backed |
$ | |||||||
Other asset-backed |
$ |
• | Internal models: |
• | Broker quotes: |
• | Internal models: |
March 31, 2021 |
||||||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
NAV (1) |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | $ | $ | |||||||||||||||
State and political subdivisions |
||||||||||||||||||||
Non-U.S. government |
||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
||||||||||||||||||||
Energy |
||||||||||||||||||||
Finance and insurance |
||||||||||||||||||||
Consumer—non-cyclical |
||||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
||||||||||||||||||||
Consumer—cyclical |
||||||||||||||||||||
Transportation |
||||||||||||||||||||
Other |
||||||||||||||||||||
Total U.S. corporate |
||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
||||||||||||||||||||
Energy |
||||||||||||||||||||
Finance and insurance |
||||||||||||||||||||
Consumer—non-cyclical |
||||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
||||||||||||||||||||
Consumer—cyclical |
||||||||||||||||||||
Transportation |
||||||||||||||||||||
Other |
||||||||||||||||||||
Total non-U.S. corporate |
||||||||||||||||||||
Residential mortgage-backed |
||||||||||||||||||||
Commercial mortgage-backed |
||||||||||||||||||||
Other asset-backed |
||||||||||||||||||||
Total fixed maturity securities |
||||||||||||||||||||
Equity securities |
||||||||||||||||||||
Other invested assets: |
||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||
Interest rate swaps |
||||||||||||||||||||
Equity index options |
||||||||||||||||||||
Other foreign currency contracts |
||||||||||||||||||||
Total derivative assets |
||||||||||||||||||||
Securities lending collateral |
||||||||||||||||||||
Short-term investments |
||||||||||||||||||||
Limited partnerships |
||||||||||||||||||||
Total other invested assets |
||||||||||||||||||||
Reinsurance recoverable (2) |
||||||||||||||||||||
Separate account assets |
||||||||||||||||||||
Total assets |
$ | $ | $ | $ | $ | |||||||||||||||
(1) |
Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
December 31, 2020 |
||||||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
NAV (1) |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | $ | $ | |||||||||||||||
State and political subdivisions |
||||||||||||||||||||
Non-U.S. government |
||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
||||||||||||||||||||
Energy |
||||||||||||||||||||
Finance and insurance |
||||||||||||||||||||
Consumer—non-cyclical |
||||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
||||||||||||||||||||
Consumer—cyclical |
||||||||||||||||||||
Transportation |
||||||||||||||||||||
Other |
||||||||||||||||||||
Total U.S. corporate |
||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
||||||||||||||||||||
Energy |
||||||||||||||||||||
Finance and insurance |
||||||||||||||||||||
Consumer—non-cyclical |
||||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
||||||||||||||||||||
Consumer—cyclical |
||||||||||||||||||||
Transportation |
||||||||||||||||||||
Other |
||||||||||||||||||||
Total non-U.S. corporate |
||||||||||||||||||||
Residential mortgage-backed |
||||||||||||||||||||
Commercial mortgage-backed |
||||||||||||||||||||
Other asset-backed |
||||||||||||||||||||
Total fixed maturity securities |
||||||||||||||||||||
Equity securities |
||||||||||||||||||||
Other invested assets: |
||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||
Interest rate swaps |
||||||||||||||||||||
Foreign currency swaps |
||||||||||||||||||||
Equity index options |
||||||||||||||||||||
Other foreign currency contracts |
||||||||||||||||||||
Total derivative assets |
||||||||||||||||||||
Securities lending collateral |
||||||||||||||||||||
Short-term investments |
||||||||||||||||||||
Limited partnerships |
||||||||||||||||||||
Total other invested assets |
||||||||||||||||||||
Reinsurance recoverable (2) |
||||||||||||||||||||
Separate account assets |
||||||||||||||||||||
Total assets |
$ | $ | $ | $ | $ | |||||||||||||||
(1) |
Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
Beginning balance as of January 1, 2021 |
Total realized and unrealized gains (losses) |
Ending balance as of March 31, 2021 |
Total gains (losses) attributable to assets still held |
|||||||||||||||||||||||||||||||||||||||||||||
Included in |
Transfer |
Transfer |
Included |
|||||||||||||||||||||||||||||||||||||||||||||
net income |
Included |
into |
out of |
in net |
Included |
|||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) |
(loss) |
in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Level 3 (1) |
Level 3 (1) |
income (loss) |
in OCI |
||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||||||||||||||
State and political subdivisions |
$ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Industrial |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Total U.S. corporate |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Technology and communications |
||||||||||||||||||||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Total non-U.S. corporate |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Total fixed maturity securities |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Equity securities |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Other invested assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Equity index options |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Total derivative assets |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Total other invested assets |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance recoverable (2) |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Total Level 3 assets |
$ | $ | ( |
) | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | ||||||||||||||||||||||
(1) |
The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
Beginning balance as of January 1, 2020 |
Total realized and unrealized gains (losses) |
Ending balance as of March 31, 2020 |
Total gains (losses) attributable to assets still held |
|||||||||||||||||||||||||||||||||||||||||||||
Included in |
Transfer |
Transfer |
Included |
|||||||||||||||||||||||||||||||||||||||||||||
net income |
Included |
into |
out of |
in net |
Included |
|||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) |
(loss) |
in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Level 3 (1) |
Level 3 (1) |
income (loss) |
in OCI |
||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||||||||||||||
State and political subdivisions |
$ | $ | $ | ( |
) | $ | $ | $ | $ | ( |
) | $ | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||||||
Non-U.S. government |
||||||||||||||||||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Total U.S. corporate |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Total non-U.S. corporate |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Total fixed maturity securities |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||
Equity securities |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Other invested assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Equity index options |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Total derivative assets |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Total other invested assets |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Reinsurance recoverable (2) |
||||||||||||||||||||||||||||||||||||||||||||||||
Total Level 3 assets |
$ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||
(1) |
The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
(Amounts in millions) |
2021 |
2020 |
||||||
Total realized and unrealized gains (losses) included in net income (loss): |
||||||||
Net investment income |
$ | $ | ||||||
Net investment gains (losses) |
( |
) | ||||||
Total |
$ | ( |
) | $ | ||||
Net gains (losses) included in net income (loss) attributable to assets still held: |
||||||||
Net investment income |
$ | $ | ||||||
Net investment gains (losses) |
( |
) | ||||||
Total |
$ | ( |
) | $ | ||||
(Amounts in millions) |
Valuation technique |
Fair value |
Unobservable input |
Range |
Weighted-average (1) |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
$ | Credit spreads | ||||||||||||||||||
Energy |
Credit spreads | Not applicable | ||||||||||||||||||
Finance and insurance |
Credit spreads | |||||||||||||||||||
Consumer—non-cyclical |
Credit spreads | |||||||||||||||||||
Technology and communications |
Credit spreads | |||||||||||||||||||
Industrial |
Credit spreads | |||||||||||||||||||
Capital goods |
Credit spreads | |||||||||||||||||||
Consumer—cyclical |
Credit spreads | |||||||||||||||||||
Transportation |
Credit spreads | |||||||||||||||||||
Other |
Credit spreads | |||||||||||||||||||
Total U.S. corporate |
$ | Credit spreads | ||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
$ | Credit spreads | ||||||||||||||||||
Energy |
Credit spreads | |||||||||||||||||||
Finance and insurance |
Credit spreads | |||||||||||||||||||
Consumer—non-cyclical |
Credit spreads | |||||||||||||||||||
Technology and communications |
Credit spreads | |||||||||||||||||||
Industrial |
Credit spreads | |||||||||||||||||||
Capital goods |
Credit spreads | |||||||||||||||||||
Consumer—cyclical |
Credit spreads | |||||||||||||||||||
Transportation |
Credit spreads | |||||||||||||||||||
Other |
Credit spreads | |||||||||||||||||||
Total non-U.S. corporate |
$ | Credit spreads | ||||||||||||||||||
Derivative assets: |
||||||||||||||||||||
Equity index options |
cash flows |
|
$ | Equity index volatility |
|
(1) |
Unobservable inputs weighted by the relative fair value of the associated instrument for fixed maturity securities and by notional for derivative assets. |
March 31, 2021 |
||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Liabilities |
||||||||||||||||
Policyholder account balances: |
||||||||||||||||
GMWB embedded derivatives (1) |
$ | $ | $ | $ | ||||||||||||
Fixed index annuity embedded derivatives |
||||||||||||||||
Indexed universal life embedded derivatives |
||||||||||||||||
Total policyholder account balances |
||||||||||||||||
Derivative liabilities: |
||||||||||||||||
Interest rate swaps |
||||||||||||||||
Foreign currency swaps |
||||||||||||||||
Total derivative liabilities |
||||||||||||||||
Total liabilities |
$ | $ | $ | $ | ||||||||||||
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
December 31, 2020 |
||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Liabilities |
||||||||||||||||
Policyholder account balances: |
||||||||||||||||
GMWB embedded derivatives (1) |
$ | $ | $ | $ | ||||||||||||
Fixed index annuity embedded derivatives |
||||||||||||||||
Indexed universal life embedded derivatives |
||||||||||||||||
Total policyholder account balances |
||||||||||||||||
Derivative liabilities: |
||||||||||||||||
Interest rate swaps |
||||||||||||||||
Foreign currency swaps |
||||||||||||||||
Other foreign currency contracts |
||||||||||||||||
Total derivative liabilities |
||||||||||||||||
Total liabilities |
$ | $ | $ | $ | ||||||||||||
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
Beginning balance as of January 1, 2021 |
Total realized and |
Ending balance as of March 31, 2021 |
Total (gains) losses |
|||||||||||||||||||||||||||||||||||||||||||||
unrealized (gains) |
attributable to |
|||||||||||||||||||||||||||||||||||||||||||||||
losses |
liabilities still held |
|||||||||||||||||||||||||||||||||||||||||||||||
Included in |
Transfer |
Transfer |
Included |
|||||||||||||||||||||||||||||||||||||||||||||
net (income) |
Included |
into |
out of |
in net |
Included |
|||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) |
loss |
in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Level 3 |
Level 3 |
(income) loss |
in OCI |
||||||||||||||||||||||||||||||||||||||
Policyholder account balances: |
||||||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (1) |
$ | $ | ( |
) | $ | $ | $ | $ | $ | $ | $ | $ | $ | ( |
) | $ | ||||||||||||||||||||||||||||||||
Fixed index annuity embedded derivatives |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Total policyholder account balances |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Total Level 3 liabilities |
$ | $ | ( |
) | $ | $ | $ | $ | $ | ( |
) | $ | $ | $ | $ | ( |
) | $ | ||||||||||||||||||||||||||||||
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
Beginning balance as of January 1, 2020 |
Total realized and |
Ending balance as of March 31, 2020 |
Total (gains) losses |
|||||||||||||||||||||||||||||||||||||||||||||
unrealized (gains) |
attributable to |
|||||||||||||||||||||||||||||||||||||||||||||||
losses |
liabilities still held |
|||||||||||||||||||||||||||||||||||||||||||||||
Included in |
Transfer |
Transfer |
Included |
|||||||||||||||||||||||||||||||||||||||||||||
net (income) |
Included |
into |
out of |
in net |
Included |
|||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) |
loss |
in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Level 3 |
Level 3 |
(income) loss |
in OCI |
||||||||||||||||||||||||||||||||||||||
Policyholder account balances: |
||||||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (1) |
$ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||
Fixed index annuity embedded derivatives |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Total policyholder account balances |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Total Level 3 liabilities |
$ | $ | $ | $ | $ | $ | $ | ( |
) | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
(Amounts in millions) |
2021 |
2020 |
||||||
Total realized and unrealized (gains) losses included in net (income) loss: |
||||||||
Net investment income |
$ | $ | ||||||
Net investment (gains) losses |
( |
) | ||||||
Total |
$ | ( |
) | $ | ||||
Total (gains) losses included in net (income) loss attributable to liabilities still held: |
||||||||
Net investment income |
$ | $ | ||||||
Net investment (gains) losses |
( |
) | ||||||
Total |
$ | ( |
) | $ | ||||
(Amounts in millions) |
Valuation technique |
Fair value |
Unobservable input |
Range |
Weighted-average (1) | |||||||||
Policyholder account balances: |
||||||||||||||
Withdrawal utilization rate |
||||||||||||||
Lapse rate | ||||||||||||||
Non-performance risk (credit spreads) |
||||||||||||||
GMWB embedded derivatives (2) |
model |
|
$ | Equity index volatility |
||||||||||
Fixed index annuity embedded derivatives |
method |
|
$ | Expected future interest credited |
||||||||||
Indexed universal life embedded derivatives |
method |
|
$ | Expected future interest credited |
(1) |
Unobservable inputs weighted by the policyholder account balances associated with the instrument. |
(2) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. The unobservable inputs associated with GMWB embedded derivatives are not interrelated and therefore, a directional change in one input will not affect the other inputs. |
March 31, 2021 |
||||||||||||||||||||||||
(Amounts in millions) |
Notional amount |
Carrying amount |
Fair value |
|||||||||||||||||||||
Total |
Level 1 |
Level 2 |
Level 3 |
|||||||||||||||||||||
Assets: |
||||||||||||||||||||||||
Commercial mortgage loans |
(1) |
$ | $ | $ | $ | $ | ||||||||||||||||||
Bank loan investments |
(1) |
|||||||||||||||||||||||
Liabilities: |
||||||||||||||||||||||||
Long-term borrowings |
(1) |
|||||||||||||||||||||||
Investment contracts |
(1) |
|||||||||||||||||||||||
Other firm commitments: |
||||||||||||||||||||||||
Commitments to fund limited partnerships |
||||||||||||||||||||||||
Commitments to fund bank loan investments |
||||||||||||||||||||||||
Ordinary course of business lending commitments |
(1) |
These financial instruments do not have notional amounts. |
December 31, 2020 |
||||||||||||||||||||||||
(Amounts in millions) |
Notional amount |
Carrying amount |
Fair value |
|||||||||||||||||||||
Total |
Level 1 |
Level 2 |
Level 3 |
|||||||||||||||||||||
Assets: |
||||||||||||||||||||||||
Commercial mortgage loans |
(1) |
$ | $ | $ | $ | $ | ||||||||||||||||||
Bank loan investments |
(1) |
|||||||||||||||||||||||
Liabilities: |
||||||||||||||||||||||||
Long-term borrowings |
(1) |
|||||||||||||||||||||||
Investment contracts |
(1) |
|||||||||||||||||||||||
Other firm commitments: |
||||||||||||||||||||||||
Commitments to fund limited partnerships |
||||||||||||||||||||||||
Commitments to fund bank loan investments |
||||||||||||||||||||||||
Ordinary course of business lending commitments |
(1) |
These financial instruments do not have notional amounts. |
As of or for the three |
||||||||
months ended |
||||||||
March 31, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Beginning balance |
$ | $ | ||||||
Less reinsurance recoverables |
( |
) | ( |
) | ||||
Net beginning balance |
||||||||
Incurred related to insured events of: |
||||||||
Current year |
||||||||
Prior years |
( |
) | ( |
) | ||||
Total incurred |
||||||||
Paid related to insured events of: |
||||||||
Current year |
( |
) | ( |
) | ||||
Prior years |
( |
) | ( |
) | ||||
Total paid |
( |
) | ( |
) | ||||
Interest on liability for policy and contract claims |
||||||||
Foreign currency translation |
( |
) | ||||||
Net ending balance |
||||||||
Add reinsurance recoverables |
||||||||
Ending balance |
$ | $ | ||||||
March 31, |
December 31, |
|||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Genworth Holdings (1) |
||||||||
$ | $ | |||||||
Floating Rate Junior Subordinated Notes, due |
||||||||
Subtotal |
||||||||
Bond consent fees |
( |
) | ( |
) | ||||
Deferred borrowing charges |
( |
) | ( |
) | ||||
Total Genworth Holdings |
||||||||
Genworth Mortgage Holdings, Inc. |
||||||||
(2) |
||||||||
Deferred borrowing charges |
( |
) | ( |
) | ||||
Total Genworth Mortgage Holdings, Inc. |
||||||||
Total |
$ |
$ | ||||||
(1) |
We have the option to redeem all or a portion of the senior notes at any time with notice to the noteholders at a price equal to the greater of 100% of principal or the sum of the present value of the remaining scheduled payments of principal and interest discounted at the then-current treasury rate plus an applicable spread. |
(2) |
Senior notes issued by Genworth Mortgage Holdings, Inc. (“GMHI”), our wholly-owned U.S. mortgage insurance subsidiary, who has the option to redeem the notes in whole or in part at any time prior to February 15, 2025, by paying a make-whole premium plus accrued and unpaid interest. |
Three months ended March 31, |
||||||||
2021 |
2020 |
|||||||
Statutory U.S. federal income tax rate |
% | % | ||||||
Increase (reduction) in rate resulting from: |
||||||||
Swaps terminated prior to the TCJA (1) |
( |
) | ||||||
Stock-based compensation |
( |
) | ||||||
Nondeductible expenses |
( |
) | ||||||
Other, net |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Effective rate |
% | % | ||||||
|
|
|
|
(1) |
Tax Cuts and Jobs Act |
Three months ended |
||||||||
March 31, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Revenues: |
||||||||
U.S. Mortgage Insurance segment |
$ | $ | ||||||
U.S. Life Insurance segment: |
||||||||
Long-term care insurance |
||||||||
Life insurance |
||||||||
Fixed annuities |
||||||||
U.S. Life Insurance segment |
||||||||
Runoff segment |
||||||||
Corporate and Other activities |
||||||||
Total revenues |
$ | $ | ||||||
Three months ended |
||||||||
March 31, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ( |
) | ||||
Add: net income from continuing operations attributable to noncontrolling interests |
||||||||
Add: net income (loss) from discontinued operations attributable to noncontrolling interests |
( |
) | ||||||
Net income (loss) |
( |
) | ||||||
Less: income (loss) from discontinued operations, net of taxes |
( |
) | ||||||
Income (loss) from continuing operations |
( |
) | ||||||
Less: net income from continuing operations attributable to noncontrolling interests |
||||||||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders |
( |
) | ||||||
Adjustments to income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders: |
||||||||
Net investment (gains) losses, net (1) |
( |
) | ||||||
Losses on early extinguishment of debt |
||||||||
Expenses related to restructuring |
||||||||
Taxes on adjustments |
( |
) | ||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
(1) |
For the three months ended March 31, 2020, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $( |
Three months ended |
||||||||
March 31, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||
U.S. Mortgage Insurance segment |
$ | $ | ||||||
U.S. Life Insurance segment: |
||||||||
Long-term care insurance |
||||||||
Life insurance |
( |
) | ( |
) | ||||
Fixed annuities |
||||||||
U.S. Life Insurance segment |
( |
) | ||||||
Runoff segment |
( |
) | ||||||
Corporate and Other activities |
( |
) | ( |
) | ||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
March 31, |
December 31, |
|||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Assets: |
||||||||
U.S. Mortgage Insurance segment |
$ | $ | ||||||
U.S. Life Insurance segment |
||||||||
Runoff segment |
||||||||
Corporate and Other activities |
||||||||
Segment assets from continuing operations |
||||||||
Assets related to discontinued operations |
||||||||
Total assets |
$ | $ | ||||||
Net |
Foreign |
|||||||||||||||
unrealized |
currency |
|||||||||||||||
investment |
Derivatives |
translation |
||||||||||||||
gains |
qualifying as |
and other |
||||||||||||||
(Amounts in millions) |
(losses) (1) |
hedges (2) |
adjustments |
Total |
||||||||||||
Balances as of January 1, 2021 |
$ | $ | $ | $ | ||||||||||||
OCI before reclassifications |
( |
) | ( |
) | ( |
) | ||||||||||
Amounts reclassified from (to) OCI |
( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Current period OCI |
( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balances as of March 31, 2021 before noncontrolling interests |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Less: change in OCI attributable to noncontrolling interests |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balances as of March 31, 2021 |
$ | $ | $ | ( |
) | $ | ||||||||||
|
|
|
|
|
|
|
|
(1) |
Net of adjustments to DAC, present value of future profits, sales inducements and benefit reserves. See note 4 for additional information. |
(2) |
See note 5 for additional information. |
Net |
Foreign |
|||||||||||||||
unrealized |
currency |
|||||||||||||||
investment |
Derivatives |
translation |
||||||||||||||
gains |
qualifying as |
and other |
||||||||||||||
(Amounts in millions) |
(losses) (1) |
hedges (2) |
adjustments |
Total |
||||||||||||
Balances as of January 1, 2020 |
$ | $ | $ | ( |
) | $ | ||||||||||
OCI before reclassifications |
( |
) | ( |
) | ||||||||||||
Amounts reclassified from (to) OCI |
( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Current period OCI |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balances as of March 31, 2020 before noncontrolling interests |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Less: change in OCI attributable to noncontrolling interests |
( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balances as of March 31, 2020 |
$ | $ | $ | ( |
) | $ | ||||||||||
|
|
|
|
|
|
|
|
(1) |
Net of adjustments to DAC, present value of future profits, sales inducements and benefit reserves. See note 4 for additional information. |
(2) |
See note 5 for additional information. |
Amount reclassified from accumulated other comprehensive income |
Affected line item in the consolidated statements of income | |||||||||
Three months ended March 31, |
||||||||||
(Amounts in millions) |
2021 |
2020 |
||||||||
Net unrealized investment (gains) losses: |
||||||||||
Unrealized (gains) losses on investments (1) |
$ | ( |
) | $ | ( |
) | Net investment (gains) losses | |||
Income taxes |
Provision for income taxes | |||||||||
|
|
|
|
|||||||
Total |
$ | ( |
) | $ | ( |
) | ||||
|
|
|
|
|||||||
Derivatives qualifying as hedges: |
||||||||||
Interest rate swaps hedging assets |
$ | ( |
) | $ | ( |
) | Net investment income | |||
Interest rate swaps hedging assets |
( |
) | Net investment (gains) losses | |||||||
Income taxes |
Provision for income taxes | |||||||||
|
|
|
|
|||||||
Total |
$ | ( |
) | $ | ( |
) | ||||
|
|
|
|
(1) |
Amounts exclude adjustments to DAC, present value of future profits, sales inducements and benefit reserves. |
(Amounts in millions) |
||||
Net cash proceeds |
$ | |||
Add: carrying value of noncontrolling interests (1) |
||||
|
|
|||
Total adjusted consideration (2) |
||||
Carrying value of the disposal group before accumulated other comprehensive (income) loss |
||||
Add: total accumulated other comprehensive (income) loss of disposal group (3) |
||||
|
|
|||
Total adjusted carrying value of the disposal group |
||||
Pre-tax loss on sale |
( |
) | ||
Tax benefit on sale |
||||
|
|
|||
After-tax loss on sale |
$ | ( |
) | |
|
|
(1) |
In accordance with accounting guidance on the deconsolidation of a subsidiary or group of assets, the carrying amount of any noncontrolling interests in the subsidiary sold (adjusted to reflect amounts in accumulated other comprehensive income (loss) recognized upon final disposition) is added to the total fair value of the consideration received. |
(2) |
Represents the aggregate of the net cash proceeds received upon sale closing plus the adjusted carrying amount of noncontrolling interests in the subsidiary sold. |
(3) |
Consists primarily of $ |
(Amounts in millions) |
March 31, 2021 |
December 31, 2020 |
||||||
Assets |
||||||||
Investments: |
||||||||
Fixed maturity securities available-for-sale, |
$ | $ | ||||||
Equity securities, at fair value |
||||||||
Other invested assets |
||||||||
|
|
|
|
|||||
Total investments |
||||||||
Cash, cash equivalents and restricted cash |
||||||||
Accrued investment income |
||||||||
Deferred acquisition costs |
||||||||
Intangible assets |
||||||||
Other assets |
||||||||
Deferred tax asset |
||||||||
|
|
|
|
|||||
Assets related to discontinued operations |
$ | $ | ||||||
|
|
|
|
|||||
Liabilities |
||||||||
Liability for policy and contract claims |
$ | $ | ||||||
Unearned premiums |
||||||||
Other liabilities |
||||||||
Long-term borrowings |
||||||||
|
|
|
|
|||||
Liabilities related to discontinued operations |
$ | $ | ||||||
|
|
|
|
Three months ended |
||||||||
March 31, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Revenues: |
||||||||
Premiums |
$ | $ | ||||||
Net investment income |
||||||||
Net investment gains (losses) |
( |
) | ( |
) | ||||
Policy fees and other income |
||||||||
|
|
|
|
|||||
Total revenues |
||||||||
|
|
|
|
|||||
Benefits and expenses: |
||||||||
Benefits and other changes in policy reserves |
||||||||
Acquisition and operating expenses, net of deferrals |
||||||||
Amortization of deferred acquisition costs and intangibles |
||||||||
Interest expense |
||||||||
|
|
|
|
|||||
Total benefits and expenses |
||||||||
|
|
|
|
|||||
Income (loss) before income taxes and loss on sale (1) |
( |
) | ||||||
Provision (benefit) for income taxes |
( |
) | ||||||
|
|
|
|
|||||
Income (loss) before loss on sale |
( |
) | ||||||
Loss on sale, net of taxes |
( |
) | ||||||
|
|
|
|
|||||
Income (loss) from discontinued operations, net of taxes |
( |
) | ||||||
|
|
|
|
|||||
Less: net income (loss) from discontinued operations attributable to noncontrolling interests |
( |
) | ||||||
|
|
|
|
|||||
Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ( |
) | ||||
|
|
|
|
(1) |
The three months ended March 31, 2021 and 2020, include pre-tax income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders of $ |
(Amounts in millions) |
British Pounds |
U.S. Dollar |
||||||||||||||
March 31, |
December 31, |
March 31, |
December 31, |
|||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Installment payments due to AXA: |
||||||||||||||||
June 2022: |
||||||||||||||||
Beginning balance |
£ | £ | $ | $ | ||||||||||||
Prepayments (1) |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Ending balance |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
September 2022: |
||||||||||||||||
Beginning balance |
||||||||||||||||
Prepayments (1) |
( |
) | ( |
) | ||||||||||||
Amounts billed as future losses |
||||||||||||||||
Foreign exchange and other |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Ending balance |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total amounts due under the promissory note |
||||||||||||||||
Future claims: |
||||||||||||||||
Estimated beginning balance |
||||||||||||||||
Change in estimated future claims |
||||||||||||||||
Less: Amounts billed |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Foreign exchange and other |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Estimated future billings |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total amounts due to AXA under the settlement agreement (2) |
£ | £ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
(1) |
On March 3, 2021, we completed the sale of Genworth Australia and received net proceeds of approximately AUD |
(2) |
Amounts exclude accrued interest on the promissory note and certain other expenses. As of March 31, 2021, due principally to the mandatory payment made in connection with the Genworth Australia sale, including approximately $ |
• | the consummation of certain qualifying debt transactions in which total gross proceeds of at least $ |
• | the consummation of certain qualifying equity issuances or dispositions with respect to GMHI, or any of our subsidiaries, in which total net cash proceeds of at least $ |
• | certain dispositions of our U.S. mortgage insurance business; |
• | transactions involving a change of control of Genworth; and |
• | receipt of dividends and sale proceeds from GMHI above certain threshold amounts. |
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
• | we may be unable to successfully execute strategic plans to effectively address our current business challenges COVID-19 delay or hinder alternative transactions or otherwise make alternative transactions less attractive; the ability to pursue alternative strategic transactions; our inability to attract buyers for any businesses or other assets we may seek to sell, or securities we may seek to issue (including a planned partial sale of our U.S. mortgage insurance business) in each case, in a timely manner and on anticipated terms; an inability to increase the capital needed in our businesses in a timely manner and on anticipated terms, including through improved business performance, reinsurance or similar transactions, asset sales, debt issuances, securities offerings or otherwise, in each case as and when required; a failure to obtain any required regulatory, stockholder, noteholder approvals and/or other third-party approvals or consents for such alternative strategic transactions; our challenges changing or being more costly or difficult to successfully address than currently anticipated or the benefits achieved being less than anticipated; an inability to achieve anticipated cost-savings in a timely manner; and adverse tax or accounting charges; |
• | risks related to the termination of the China Oceanwide transaction |
financial performance; the possibility that we may be unable to pursue potential future opportunities with China Oceanwide to offer insurance products in China; continued availability of capital and financing to us under acceptable terms; further rating agency actions and downgrades in our credit or financial strength ratings; the inability to reduce costs due to the termination of the China Oceanwide transaction, including in connection with any proposed resource alignment; and our ability to attract, recruit, retain and motivate current and prospective employees may be adversely affected due to the termination of the China Oceanwide transaction; |
• | risks relating to estimates, assumptions and valuations COVID-19; inaccurate models; deviations from our estimates and actuarial assumptions or other reasons in our long-term care insurance, life insurance and/or annuity businesses; accelerated amortization of deferred acquisition costs (“DAC”) and present value of future profits (“PVFP”) (including as a result of any future changes we may make to our assumptions, methodologies or otherwise in connection with periodic or other reviews); adverse impact on our financial results as a result of projected profits followed by projected losses (as is currently the case with our long-term care insurance business); and changes in valuation of fixed maturity and equity securities; |
• | liquidity, financial strength ratings, credit and counterparty risks COVID-19; the impact of increased leverage as a result of the AXA settlement and related restrictions; continued availability of capital and financing; future adverse rating agency actions against us or our U.S. mortgage insurance subsidiary, including with respect to rating downgrades or potential downgrades or being put on review for potential downgrade, all of which could have adverse implications, including with respect to key business relationships, product offerings, business results of operations, financial condition and capital needs, strategic plans, collateral obligations and availability and terms of hedging, reinsurance and borrowings; defaults by counterparties to reinsurance arrangements or derivative instruments; defaults or other events impacting the value of our fixed maturity securities portfolio; defaults on our commercial mortgage loans; defaults on mortgage loans or other assets underlying our investments in our mortgage and asset-backed securities and volatility in performance; |
• | risks relating to economic, market and political conditions COVID-19; interest rates and changes in rates have adversely impacted, and may continue to materially adversely impact our business and profitability; deterioration in economic conditions or a decline in home prices that adversely affect our loss experience in our U.S. mortgage insurance business; political and economic instability or changes in government policies; and fluctuations in foreign currency exchange rates and international securities markets; |
• | regulatory and legal risks |
|
|
|
dividends or make other distributions to us, including as a result of the performance of our subsidiaries, heightened regulatory restrictions resulting from COVID-19, and other insurance, regulatory or corporate law restrictions; the inability to successfully seek in-force rate action increases (including increased premiums and associated benefit reductions) in our long-term care insurance business, including as a result of COVID-19; adverse change in regulatory requirements, including risk-based capital; inability to continue to maintain the private mortgage insurer eligibility requirements (“PMIERs”); risks on our U.S. mortgage insurance subsidiary’s ability to pay our holding company dividends as a result of the government-sponsored enterprises (“GSEs”) amendments to PMIERs in response to COVID-19 or other restrictions that the GSEs may place on the ability of our U.S. mortgage insurance subsidiary to pay dividends to our holding company in connection with a planned partial sale; the impact on capital levels of increased delinquencies caused by COVID-19; inability of our U.S. mortgage insurance subsidiaries to meet minimum statutory capital requirements; the influence of Federal National Mortgage Association (“Fannie Mae”), Federal Home Loan Mortgage Corporation (“Freddie Mac”) and a small number of large mortgage lenders on the U.S. mortgage insurance market and adverse changes to the role or structure of Fannie Mae and Freddie Mac; adverse changes in regulations affecting our U.S. mortgage insurance business; additional restrictions placed on our U.S. mortgage insurance business by government and government-owned and the GSEs in connection with a new debt financing and/or sale of a percentage of our ownership interests therein; inability to continue to implement actions to mitigate the impact of statutory reserve requirements; changes in tax laws; and changes in accounting and reporting standards; |
• | operational risks shelter-in-place COVID-19; reliance on, and loss of, key customer or distribution relationships; the design and effectiveness of our disclosure controls and procedures and internal control over financial reporting may not prevent all errors, misstatements or misrepresentations; and failure or any compromise of the security of our computer systems, disaster recovery systems, business continuity plans and failures to safeguard or breaches of confidential information; |
• | insurance and product-related risks in-force long-term care insurance policies, in each case, as currently anticipated and as may be required from time to time in the future (including as a result of a delay or failure to obtain any necessary regulatory approvals, including as a result of COVID-19, or unwillingness or inability of policyholders to pay increased premiums and/or accept reduced benefits), including to offset any negative impact on our long-term care insurance margins; availability, affordability and adequacy of reinsurance to protect us against losses; decreases in the volume of mortgage originations or increases in mortgage insurance cancellations; increases in the use of alternatives to private mortgage insurance and reductions in the level of coverage selected; potential liabilities in connection with our U.S. contract underwriting services; and medical advances, such as genetic research and diagnostic imaging, and related legislation that impact policyholder behavior in ways adverse to us; |
• | other risks man-made disasters or a pandemic, similar to COVID-19, could materially adversely affect our financial condition and results of operations. |
• | We had net income available to Genworth Financial, Inc.’s common stockholders of $187 million for the three months ended March 31, 2021 compared to a net loss of $66 million for the three months ended March 31, 2020. We had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $168 million and $20 million for the three months ended March 31, 2021 and 2020, respectively. |
• | Our U.S. Mortgage Insurance segment had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $126 million and $148 million for the three months ended March 31, 2021 and 2020, respectively. The decrease was primarily from higher losses largely from new delinquencies driven primarily by an increase in borrower forbearance as a result of COVID-19, reserve strengthening of $8 million on pre-COVID-19 in-force and an increase in policy cancellations in our single premium mortgage insurance product, partially offset by higher ceded premiums and lower average premium rates in the current year. |
• | Our U.S. Life Insurance segment had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $62 million in the current year compared to an adjusted operating loss of $70 million in the prior year. |
• | Our long-term care insurance business had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $95 million and $1 million for the three months ended March 31, 2021 and 2020, respectively. The increase was primarily from higher claim terminations driven mostly by higher mortality, as well as favorable development on incurred but not reported (“IBNR”) claims and higher investment income in the current year. We also increased reserves by $76 million in the current year to account for changes to incidence and mortality experience driven by COVID-19, which we believe are temporary. |
• | Our life insurance business had an adjusted operating loss available to Genworth Financial, Inc.’s common stockholders of $63 million and $77 for the three months ended March 31, 2021 and 2020, respectively. The decrease in the loss was mainly attributable to higher reserves recorded in the prior year on our 10-year term universal life insurance block entering its post-level premium period and from lower lapses primarily associated with our large 20-year term life insurance block written in the end of 2000 as it entered its post-level premium period following the 60-day grace period, partially offset by higher mortality in our universal and term universal life insurance products and a DAC impairment of $17 million in our universal life insurance products in the current year. |
• | Our fixed annuities business had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $30 million and $6 for the three months ended March 31, 2021 and 2020, respectively. The increase was mainly attributable to lower reserves and DAC amortization in our fixed indexed annuities driven by favorable equity market and interest rate changes in the current year and higher mortality in our single premium immediate annuities. |
• | Our Runoff segment had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $12 million for the three months ended March 31, 2021 compared to an adjusted operating loss of $13 million for the three months ended March 31, 2020. The increase to income in the current year from a loss in the prior year was predominantly due to favorable equity market and interest rate performance in the current year. |
• | Corporate and Other activities had an adjusted operating loss available to Genworth Financial, Inc.’s common stockholders of $32 million and $45 million for the three months ended March 31, 2021 and 2020, respectively. The decrease in the loss was primarily related to lower operating costs and interest expense in the current year. |
• | Incurred losses. COVID-19. We also strengthened reserves by $10 million during the first quarter of 2021 primarily due to our expectation that pre-COVID-19 |
• | Borrower forbearance. COVID-19. Servicer reported forbearance slowed meaningfully beginning in June 2020 and ended the first quarter of 2021 with approximately 4.9% or 45,263 of our active primary policies reported in a forbearance plan, of which approximately 64% were reported as delinquent. |
• | PMIERs compliance. non-performing due to a COVID-19 hardship, PMIERs was temporarily amended with respect to each non-performing loan. As of March 31, 2021, our U.S. mortgage insurance business had estimated available assets of $4,769 million against $3,005 million net required assets under PMIERs compared to available assets of $4,588 million against $3,359 million net required assets as of December 31, 2020. The sufficiency ratio as of March 31, 2021 was 159% or $1,764 million above the published PMIERs requirements, compared to 137% or $1,229 million above the published PMIERs requirements as of December 31, 2020. PMIERs sufficiency is based on the published requirements applicable to private mortgage insurers and does not give effect to GSE restrictions imposed on our U.S. mortgage insurance business. The increase in the PMIERs sufficiency was driven in part by the completion of an insurance linked notes transaction, which added $495 million of additional PMIERs capital credit as of March 31, 2021, elevated lapse driven by prevailing low interest rates and business cash flows, partially offset by elevated new insurance written. In addition, elevated lapse continued to drive an acceleration of the amortization of our existing reinsurance transactions, which caused a reduction in PMIERs capital credit in the first quarter of 2021. Our PMIERs required assets as of March 31, 2021 and December 31, 2020 benefited from the application of a 0.30 multiplier applied to the risk-based required asset amount factor for certain non-performing loans. The application of the 0.30 multiplier to all eligible delinquencies provided $1,012 million of benefit to our March 31, 2021 |
PMIERs required assets compared to $1,046 million benefit as of December 31, 2020. See “Item 2—U.S. Mortgage Insurance segment—Trends and conditions” for additional details. |
• | Mortgage originations and new insurance written. |
• | In-force rate actions in our long-term care insurance business.in-force rate action filings, we received 43 filing approvals from 20 states during the three months ended March 31, 2021, representing a weighted-average increase of 40% on approximately $396 million in annualized in-force premiums, or approximately $157 million of incremental annual premiums. We also submitted 5 new filings in 4 states during the three months ended March 31, 2021 on approximately $17 million in annualized in-force premiums. |
• | Profits followed by losses in our long-term care insurance business. |
• | Redemption of Genworth Holdings’ February 2021 senior notes. |
• | Repurchase of Genworth Holdings’ September 2021 senior notes. pre-tax loss of $4 million. |
• | Liquidity and contractual obligations. |
• | Mandatory payment of the AXA promissory note. |
June 2022 and partially prepaid the September 2022 installment payment. AXA and Genworth amended certain mandatory prepayment provisions of the promissory note permitting Genworth to retain a greater amount of the Genworth Australia sale proceeds. As of March 31, 2021, the remaining amount of the promissory note was $343 million and is due in September 2022. As a result of the mandatory payment, interest on the promissory note was retroactively reduced and now accrues at a rate of 2.75%. See note 14 in our unaudited condensed consolidated financial statements for additional information. |
• | Sale of our Australian mortgage insurance business. after-tax loss on sale of $3 million. See note 14 in our unaudited condensed consolidated financial statements for additional information. |
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 968 | $ | 946 | $ | 22 | 2 | % | ||||||||
Net investment income |
801 | 782 | 19 | 2 | % | |||||||||||
Net investment gains (losses) |
33 | (99 | ) | 132 | 133 | % | ||||||||||
Policy fees and other income |
183 | 180 | 3 | 2 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
1,985 | 1,809 | 176 | 10 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
1,218 | 1,337 | (119 | ) | (9 | )% | ||||||||||
Interest credited |
131 | 141 | (10 | ) | (7 | )% | ||||||||||
Acquisition and operating expenses, net of deferrals |
275 | 237 | 38 | 16 | % | |||||||||||
Amortization of deferred acquisition costs and intangibles |
77 | 108 | (31 | ) | (29 | )% | ||||||||||
Interest expense |
51 | 51 | — | — | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
1,752 | 1,874 | (122 | ) | (7 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income (loss) from continuing operations before income taxes |
233 | (65 | ) | 298 | NM | (1) | ||||||||||
Provision (benefit) for income taxes |
59 | (5 | ) | 64 | NM | (1) | ||||||||||
|
|
|
|
|
|
|||||||||||
Income (loss) from continuing operations |
174 | (60 | ) | 234 | NM | (1) | ||||||||||
Income (loss) from discontinued operations, net of taxes |
21 | (12 | ) | 33 | NM | (1) | ||||||||||
|
|
|
|
|
|
|||||||||||
Net income (loss) |
195 | (72 | ) | 267 | NM | (1) | ||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
— | — | — | — | % | |||||||||||
Less: net income (loss) from discontinued operations attributable to noncontrolling interests |
8 | (6 | ) | 14 | NM | (1) | ||||||||||
|
|
|
|
|
|
|||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | 187 | $ | (66 | ) | $ | 253 | NM | (1) | |||||||
|
|
|
|
|
|
|||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders |
$ | 174 | $ | (60 | ) | $ | 234 | NM | (1) | |||||||
Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders |
13 | (6 | ) | 19 | NM | (1) | ||||||||||
|
|
|
|
|
|
|||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | 187 | $ | (66 | ) | $ | 253 | NM | (1) | |||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
• | Our U.S. Mortgage Insurance segment increased $26 million mainly attributable to higher insurance in-force and an increase in policy cancellations in our single premium mortgage insurance product driven largely by higher mortgage refinancing, partially offset by higher ceded premiums and lower average premium rates in the current year. |
• | Our U.S. Life Insurance segment decreased $4 million. Our long-term care insurance business increased $4 million largely from $23 million of increased premiums in the current year from in-force rate actions approved and implemented, partially offset by policy terminations and policies entering paid-up status in the current year. Our life insurance business decreased $8 million mainly attributable to the continued runoff of our term and whole life insurance products in the current year. |
• | Our U.S. Life Insurance segment decreased $142 million. Our long-term care insurance business decreased $99 million primarily due to an increase in claim terminations driven mostly by higher mortality and favorable development on IBNR claims. These decreases were partially offset by aging of the in-force block and higher incremental reserves of $133 million recorded in connection with an accrual for profits followed by losses. In addition, we increased claim reserves by $67 million reflecting our assumption that COVID-19 accelerated our mortality experience on the most vulnerable claimants, leaving the remaining claim population less likely to terminate compared to the pre-pandemic average population. Given our assumption that COVID-19 has temporarily decreased the number of new claims submitted, IBNR reserves were also strengthened by $29 million, partially offsetting the favorable development on IBNR claims. Our life insurance business decreased $20 million primarily attributable to higher reserves recorded in the prior year on our 10-year term universal life insurance block which entered its post-level premium period, partially offset by higher mortality in our universal and term universal life insurance products in the current year compared to the prior year. Our fixed annuities business decreased $23 million principally from lower reserves in our fixed indexed annuities driven by favorable equity market and interest rate changes in the current year compared to an unfavorable market in the prior year and higher mortality in our single premium immediate annuities in the current year. |
• | Our Runoff segment decreased $12 million primarily attributable to lower guaranteed minimum death benefit (“GMDB”) reserves in our variable annuity products due to favorable equity market and interest rate performance in the current year. |
• | Our U.S. Mortgage Insurance segment increased $36 million largely from higher new delinquencies driven primarily by an increase in borrower forbearance as a result of COVID-19, reserve strengthening of $10 million primarily due to our expectation that pre-COVID-19 |
• | Our U.S. Life Insurance segment increased $41 million predominantly related to our long-term care insurance business principally related to higher premium taxes, commissions and other expenses of $26 million associated with our in-force rate action plan and restructuring costs of $10 million in the current year. |
• | Our U.S. Mortgage Insurance segment increased $7 million primarily attributable to higher operating costs in the current year. |
• | Corporate and Other activities decreased $10 million mainly driven by lower operating expenses and a make-whole premium of $9 million in the prior year related to the early redemption of Genworth Holdings’ senior notes originally scheduled to mature in June 2020, partially offset by higher employee-related expenses primarily related to restructuring costs of $7 million and a loss of $4 million in the current year related to the repurchase of Genworth Holdings’ senior notes due in September 2021. |
• | Our U.S. Life Insurance segment decreased $19 million. Our life insurance business decreased $3 million principally from prior year lapses in the large 20-year term life insurance block written in 2000, partially offset by a DAC impairment of $22 million in our universal life insurance products largely due to lower future estimated gross profits. Our fixed annuities business decreased $16 million primarily related to lower DAC amortization reflecting the impact of favorable market changes in the current year. |
• | Our Runoff segment decreased $12 million mainly related to lower DAC amortization in our variable annuity products principally from favorable equity market performance in the current year. |
• | Our U.S. Mortgage Insurance segment increased $13 million in the current year related to senior notes issued by GMHI in August 2020. |
• | Corporate and Other activities decreased $8 million largely driven by the repayment of Genworth Holdings’ senior notes due in February 2021, the repurchase of Genworth Holdings’ senior notes due in September 2021 and the early redemption of Genworth Holdings’ senior notes in the prior year originally scheduled to mature in June 2020. |
• | Our U.S. Life Insurance segment decreased $5 million due to our life insurance business principally related to the early redemption of non-recourse funding obligations in the prior year. |
Three months ended March 31, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | 187 | $ | (66 | ) | |||
Add: net income from continuing operations attributable to noncontrolling interests |
— | — | ||||||
Add: net income (loss) from discontinued operations attributable to noncontrolling interests |
8 | (6 | ) | |||||
|
|
|
|
|||||
Net income (loss) |
195 | (72 | ) | |||||
Less: income (loss) from discontinued operations, net of taxes |
21 | (12 | ) | |||||
|
|
|
|
|||||
Income (loss) from continuing operations |
174 | (60 | ) | |||||
Less: net income from continuing operations attributable to noncontrolling interests |
— | — | ||||||
|
|
|
|
|||||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders |
174 | (60 | ) | |||||
Adjustments to income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders: |
||||||||
Net investment (gains) losses, net (1) |
(33 | ) | 88 | |||||
(Gains) losses on early extinguishment of debt |
4 | 12 | ||||||
Expenses related to restructuring |
21 | 1 | ||||||
Taxes on adjustments |
2 | (21 | ) | |||||
|
|
|
|
|||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 168 | $ | 20 | ||||
|
|
|
|
(1) |
For the three months ended March 31, 2020, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(11) million. |
Three months ended March 31, |
||||||||
(Amounts in millions, except per share amounts) |
2021 |
2020 |
||||||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||
Basic |
$ | 0.35 | $ | (0.12 | ) | |||
|
|
|
|
|||||
Diluted |
$ | 0.34 | $ | (0.12 | ) | |||
|
|
|
|
|||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||
Basic |
$ | 0.37 | $ | (0.13 | ) | |||
|
|
|
|
|||||
Diluted |
$ | 0.37 | $ | (0.13 | ) | |||
|
|
|
|
|||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||
Basic |
$ | 0.33 | $ | 0.04 | ||||
|
|
|
|
|||||
Diluted |
$ | 0.33 | $ | 0.04 | ||||
|
|
|
|
|||||
Weighted-average common shares outstanding: |
||||||||
Basic |
506.0 | 504.3 | ||||||
|
|
|
|
|||||
Diluted (1) |
513.8 | 504.3 | ||||||
|
|
|
|
(1) |
Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended March 31, 2020, we were required to use basic weighted-average common shares outstanding as the inclusion of shares for stock options, restricted stock units and stock appreciation rights of 5.4 million would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended March 31, 2020, dilutive potential weighted-average common shares outstanding would have been 509.7 million. |
• | GMICO to maintain 115% of PMIERs minimum required assets through 2021, 120% during 2022 and 125% thereafter; |
• | GMHI to retain $300 million of its holding company cash that can be drawn down exclusively for its debt service or to contribute to GMICO to meet their regulatory capital needs including PMIERs; and |
• | written approval must be received from the GSEs prior to any additional debt issuance by either GMICO or GMHI. |
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 252 | $ | 226 | $ | 26 | 12 | % | ||||||||
Net investment income |
35 | 33 | 2 | 6 | % | |||||||||||
Net investment gains (losses) |
(1 | ) | — | (1 | ) | NM | (1) | |||||||||
Policy fees and other income |
2 | 2 | — | — | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
288 | 261 | 27 | 10 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
55 | 19 | 36 | 189 | % | |||||||||||
Acquisition and operating expenses, net of deferrals |
57 | 50 | 7 | 14 | % | |||||||||||
Amortization of deferred acquisition costs and intangibles |
4 | 4 | — | — | % | |||||||||||
Interest expense |
13 | — | 13 | NM | (1) | |||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
129 | 73 | 56 | 77 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations before income taxes |
159 | 188 | (29 | ) | (15 | )% | ||||||||||
Provision for income taxes |
34 | 40 | (6 | ) | (15 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
125 | 148 | (23 | ) | (16 | )% | ||||||||||
Adjustments to income from continuing operations: |
||||||||||||||||
Net investment (gains) losses |
1 | — | 1 | NM | (1) | |||||||||||
Taxes on adjustments |
— | — | — | — | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 126 | $ | 148 | $ | (22 | ) | (15 | )% | |||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
As of or for the three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Primary insurance in-force (1) |
$ | 210,200 | $ | 188,000 | $ | 22,200 | 12 | % | ||||||||
Risk in-force: |
||||||||||||||||
Primary |
$ | 52,900 | $ | 47,700 | $ | 5,200 | 11 | % | ||||||||
Pool |
100 | 200 | (100 | ) | (50 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total risk in-force |
$ | 53,000 | $ | 47,900 | $ | 5,100 | 11 | % | ||||||||
|
|
|
|
|
|
|||||||||||
New insurance written |
$ | 24,900 | $ | 17,900 | $ | 7,000 | 39 | % | ||||||||
Net premiums written |
$ | 226 | $ | 208 | $ | 18 | 9 | % |
(1) |
Primary insurance in-force represents the aggregate unpaid principal balance for loans we insure. Original loan balances are primarily used to determine premiums. |
Three months ended March 31, |
Increase (decrease) |
|||||||||||
2021 |
2020 |
2021 vs. 2020 |
||||||||||
Loss ratio |
22 | % | 8 | % | 14 | % | ||||||
Expense ratio (net earned premiums) |
24 | % | 24 | % | — | % |
(Amounts in millions) |
2021 |
2020 |
||||||
Primary insurance in-force by loan-to-value |
||||||||
95.01% and above |
$ | 33,757 | $ | 32,760 | ||||
90.01% to 95.00% |
92,124 | 85,736 | ||||||
80.01% to 90.00% |
84,218 | 69,375 | ||||||
80.00% and below |
88 | 110 | ||||||
|
|
|
|
|||||
Total |
$ | 210,187 | $ | 187,981 | ||||
|
|
|
|
|||||
Primary risk in-force by loan-to-value |
||||||||
95.01% and above |
$ | 9,151 | $ | 8,482 | ||||
90.01% to 95.00% |
26,637 | 24,703 | ||||||
80.01% to 90.00% |
17,060 | 14,532 | ||||||
80.00% and below |
18 | 23 | ||||||
|
|
|
|
|||||
Total |
$ | 52,866 | $ | 47,740 | ||||
|
|
|
|
|||||
Primary insurance in-force by FICO score at origination: |
||||||||
Over 760 |
$ | 79,285 | $ | 71,703 | ||||
740-759 |
33,607 | 31,215 | ||||||
720-739 |
30,295 | 27,210 | ||||||
700-719 |
26,309 | 22,484 | ||||||
680-699 |
20,777 | 17,460 | ||||||
660-679 (1) |
10,001 | 8,494 | ||||||
640-659 |
5,981 | 5,377 | ||||||
620-639 |
2,893 | 2,759 | ||||||
<620 |
1,039 | 1,279 | ||||||
|
|
|
|
|||||
Total |
$ | 210,187 | $ | 187,981 | ||||
|
|
|
|
|||||
Primary risk in-force by FICO score at origination: |
||||||||
Over 760 |
$ | 19,829 | $ | 18,216 | ||||
740-759 |
8,442 | 7,986 | ||||||
720-739 |
7,715 | 6,970 | ||||||
700-719 |
6,678 | 5,688 | ||||||
680-699 |
5,231 | 4,417 | ||||||
660-679 (1) |
2,484 | 2,110 | ||||||
640-659 |
1,485 | 1,322 | ||||||
620-639 |
734 | 701 | ||||||
<620 |
268 | 330 | ||||||
|
|
|
|
|||||
Total |
$ | 52,866 | $ | 47,740 | ||||
|
|
|
|
(1) |
Loans with unknown FICO scores are included in the 660-679 category. |
March 31, 2021 |
December 31, 2020 |
March 31, 2020 |
||||||||||
Primary insurance: |
||||||||||||
Insured loans in-force |
922,186 | 924,624 | 868,111 | |||||||||
Delinquent loans |
41,332 | 44,904 | 15,417 | |||||||||
Percentage of delinquent loans (delinquency rate) |
4.48 | % | 4.86 | % | 1.78 | % |
March 31, 2021 |
||||||||||||||||
(Dollar amounts in millions) |
Delinquencies |
Direct case reserves (1) |
Risk in-force |
Reserves as % of risk in-force |
||||||||||||
Payments in default: |
||||||||||||||||
3 payments or less |
8,296 | $ | 40 | $ | 436 | 9 | % | |||||||||
4 - 11 payments |
21,011 | 227 | 1,232 | 18 | % | |||||||||||
12 payments or more |
12,025 | 297 | 724 | 41 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total |
41,332 | $ | 564 | $ | 2,392 | 24 | % | |||||||||
|
|
|
|
|
|
December 31, 2020 |
||||||||||||||||
(Dollar amounts in millions) |
Delinquencies |
Direct case reserves (1) |
Risk in-force |
Reserves as % of risk in-force |
||||||||||||
Payments in default: |
||||||||||||||||
3 payments or less |
10,484 | $ | 43 | $ | 549 | 8 | % | |||||||||
4 - 11 payments |
30,324 | 331 | 1,853 | 18 | % | |||||||||||
12 payments or more |
4,096 | 143 | 204 | 70 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total |
44,904 | $ | 517 | $ | 2,606 | 20 | % | |||||||||
|
|
|
|
|
|
(1) |
Direct primary case reserves exclude loss adjustment expenses, IBNR and reinsurance reserves. |
Percent of primary risk in-force as ofMarch 31, 2021 |
Percent of direct case reserves as of March 31, 2021 (1) |
Delinquency rate as of |
||||||||||||||||||
March 31, 2021 |
December 31, 2020 |
March 31, 2020 |
||||||||||||||||||
By State: |
||||||||||||||||||||
California |
12 | % | 11 | % | 5.76 | % | 6.20 | % | 1.32 | % | ||||||||||
Texas |
8 | % | 8 | % | 5.25 | % | 5.82 | % | 1.82 | % | ||||||||||
Florida (2) |
7 | % | 10 | % | 5.97 | % | 6.92 | % | 1.96 | % | ||||||||||
Illinois (2) |
5 | % | 6 | % | 5.07 | % | 5.21 | % | 2.14 | % | ||||||||||
New York (2) |
5 | % | 12 | % | 6.36 | % | 6.92 | % | 2.69 | % | ||||||||||
Michigan |
4 | % | 2 | % | 2.68 | % | 2.93 | % | 1.30 | % | ||||||||||
Arizona |
4 | % | 2 | % | 4.06 | % | 4.54 | % | 1.28 | % | ||||||||||
North Carolina |
3 | % | 2 | % | 3.60 | % | 3.84 | % | 1.65 | % | ||||||||||
Washington |
3 | % | 3 | % | 5.47 | % | 5.37 | % | 1.09 | % | ||||||||||
Pennsylvania (2) |
3 | % | 3 | % | 3.83 | % | 4.11 | % | 1.94 | % |
(1) |
Direct primary case reserves exclude loss adjustment expenses, IBNR and reinsurance reserves. |
(2) |
Jurisdiction predominantly uses a judicial foreclosure process, which generally increases the amount of time it takes for a foreclosure to be complete. |
Percent of primary risk in-force as ofMarch 31, 2021 |
Percent of direct case reserves as of March 31, 2021 (1) |
Delinquency rate as of |
||||||||||||||||||
March 31, 2021 |
December 31, 2020 |
March 31, 2020 |
||||||||||||||||||
By MSA or MD: |
||||||||||||||||||||
Chicago-Naperville MD |
3 | % | 4 | % | 6.28 | % | 6.36 | % | 2.34 | % | ||||||||||
Phoenix MSA |
3 | % | 2 | % | 4.12 | % | 4.63 | % | 1.28 | % | ||||||||||
New York MD |
3 | % | 8 | % | 9.56 | % | 10.25 | % | 3.55 | % | ||||||||||
Atlanta MSA |
2 | % | 3 | % | 6.10 | % | 6.68 | % | 2.12 | % | ||||||||||
Washington DC-Arlington MD |
2 | % | 2 | % | 5.84 | % | 6.09 | % | 1.44 | % | ||||||||||
Houston MSA |
2 | % | 3 | % | 6.89 | % | 7.59 | % | 2.34 | % | ||||||||||
Riverside-San Bernardino MSA |
2 | % | 2 | % | 6.53 | % | 7.08 | % | 1.86 | % | ||||||||||
Los Angeles-Long Beach MD |
2 | % | 3 | % | 7.30 | % | 7.57 | % | 1.31 | % | ||||||||||
Dallas MD |
2 | % | 2 | % | 4.59 | % | 5.10 | % | 1.74 | % | ||||||||||
Nassau-Suffolk MD |
2 | % | 4 | % | 10.13 | % | 10.64 | % | 3.25 | % |
(1) |
Direct primary case reserves exclude loss adjustment expenses, IBNR and reinsurance reserves. |
(Amounts in millions) |
Weighted average rate (1) |
Percent of direct case reserves (2) |
Primary insurance in-force |
Percent of total |
Primary risk in-force |
Percent of total |
Delinquency rate |
|||||||||||||||||||||
Policy Year |
||||||||||||||||||||||||||||
2004 and prior |
6.15 | % | 3 | % | $ | 663 | — | % | $ | 189 | — | % | 16.74 | % | ||||||||||||||
2005 to 2008 |
5.53 | % | 26 | 9,837 | 5 | 2,516 | 5 | 13.27 | % | |||||||||||||||||||
2009 to 2013 |
4.22 | % | 2 | 2,394 | 1 | 651 | 1 | 6.29 | % | |||||||||||||||||||
2014 |
4.47 | % | 3 | 3,176 | 1 | 859 | 2 | 6.21 | % | |||||||||||||||||||
2015 |
4.16 | % | 5 | 6,729 | 3 | 1,795 | 3 | 5.69 | % | |||||||||||||||||||
2016 |
3.88 | % | 9 | 13,214 | 6 | 3,503 | 7 | 5.32 | % | |||||||||||||||||||
2017 |
4.25 | % | 11 | 13,817 | 7 | 3,556 | 7 | 6.58 | % | |||||||||||||||||||
2018 |
4.77 | % | 13 | 14,618 | 7 | 3,671 | 7 | 7.86 | % | |||||||||||||||||||
2019 |
4.21 | % | 19 | 33,429 | 16 | 8,361 | 16 | 5.73 | % | |||||||||||||||||||
2020 |
3.27 | % | 9 | 87,599 | 42 | 21,787 | 41 | 1.36 | % | |||||||||||||||||||
2021 |
2.89 | % | — | 24,711 | 12 | 5,978 | 11 | 0.03 | % | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total portfolio |
3.75 | % | 100 | % | $ | 210,187 | 100 | % | $ | 52,866 | 100 | % | 4.48 | % | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
(1) |
Average annual mortgage interest rate weighted by insurance in-force. |
(2) |
Direct primary case reserves exclude loss adjustments expenses, IBNR and reinsurance reserves. |
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 714 | $ | 718 | $ | (4 | ) | (1 | )% | |||||||
Net investment income |
716 | 695 | 21 | 3 | % | |||||||||||
Net investment gains (losses) |
42 | (70 | ) | 112 | 160 | % | ||||||||||
Policy fees and other income |
148 | 144 | 4 | 3 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
1,620 | 1,487 | 133 | 9 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
1,155 | 1,297 | (142 | ) | (11 | )% | ||||||||||
Interest credited |
90 | 100 | (10 | ) | (10 | )% | ||||||||||
Acquisition and operating expenses, net of deferrals |
192 | 151 | 41 | 27 | % | |||||||||||
Amortization of deferred acquisition costs and intangibles |
68 | 87 | (19 | ) | (22 | )% | ||||||||||
Interest expense |
— | 5 | (5 | ) | (100 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
1,505 | 1,640 | (135 | ) | (8 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income (loss) from continuing operations before income taxes |
115 | (153 | ) | 268 | 175 | % | ||||||||||
Provision (benefit) for income taxes |
32 | (27 | ) | 59 | NM | (1) | ||||||||||
|
|
|
|
|
|
|||||||||||
Income (loss) from continuing operations |
83 | (126 | ) | 209 | 166 | % | ||||||||||
Adjustments to income (loss) from continuing operations: |
||||||||||||||||
Net investment (gains) losses, net (2) |
(41 | ) | 67 | (108 | ) | (161 | )% | |||||||||
(Gains) losses on early extinguishment of debt |
— | 4 | (4 | ) | (100 | )% | ||||||||||
Expenses related to restructuring |
14 | — | 14 | NM | (1) | |||||||||||
Taxes on adjustments |
6 | (15 | ) | 21 | 140 | % | ||||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | 62 | $ | (70 | ) | $ | 132 | 189 | % | |||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
(2) |
For the three months ended March 31, 2021 and 2020, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $1 million and $(3) million, respectively. |
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Long-term care insurance |
$ | 95 | $ | 1 | $ | 94 | NM | (1) | ||||||||
Life insurance |
(63 | ) | (77 | ) | 14 | 18 | % | |||||||||
Fixed annuities |
30 | 6 | 24 | NM | (1) | |||||||||||
|
|
|
|
|
|
|||||||||||
Total adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | 62 | $ | (70 | ) | $ | 132 | 189 | % | |||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
• | Adjusted operating income available to Genworth Financial, Inc.’s common stockholders in our long-term care insurance business increased $94 million primarily from an increase in claim terminations driven mostly by higher mortality, as well as favorable development on IBNR claims and higher investment income in the current year. We also increased reserves by $76 million in the current year to account for changes to incidence and mortality experience driven by COVID-19, which we believe are temporary. |
• | The adjusted operating loss available to Genworth Financial, Inc.’s common stockholders in our life insurance business decreased $14 million mainly attributable to higher reserves recorded in the prior year on our 10-year term universal life insurance block entering its post-level premium period and from lower lapses primarily associated with our large 20-year term life insurance block written in the end of 2000 as it entered its post-level premium period following the 60-day grace period, partially offset by higher mortality in our universal and term universal life insurance products and a DAC impairment of $17 million in our universal life insurance products in the current year. |
• | Adjusted operating income available to Genworth Financial, Inc.’s common stockholders in our fixed annuities business increased $24 million mainly attributable to lower reserves and DAC amortization in our fixed indexed annuities driven by favorable equity market and interest rate changes in the current year and higher mortality in our single premium immediate annuities. |
• | Our long-term care insurance business increased $4 million largely from $23 million of increased premiums in the current year from in-force rate actions approved and implemented, partially offset by policy terminations and policies entering paid-up status in the current year. |
• | Our life insurance business decreased $8 million mainly attributable to the continued runoff of our term and whole life insurance products in the current year. |
• | Our long-term care insurance business increased $46 million largely from higher income from limited partnerships and an increase in average invested assets in the current year. |
• | Our life insurance business decreased $5 million principally related to unfavorable prepayment speed adjustments on mortgage-backed securities and lower income from bond calls in the current year. |
• | Our fixed annuities business decreased $20 million largely attributable to lower average invested assets in the current year due to block runoff. |
• | The change to net investment gains of $27 million in the current year from net investment losses of $55 million in the prior year in our long-term care insurance business was predominantly related to unrealized gains from changes in the fair value of equity securities in the current year compared to unrealized losses in the prior year and from derivative gains in the current year compared to derivative losses in the prior year. |
• | Net investment gains in our life insurance business increased $11 million predominantly from higher net derivative gains and unrealized gains from changes in the fair value of equity securities in the current year compared to unrealized losses in the prior year. |
• | The change to net investment gains of $3 million in the current year from net investment losses of $16 million in the prior year in our fixed annuities business was primarily related to net derivative gains in the current year compared to net derivative losses in the prior year. |
• | Our long-term care insurance business decreased $99 million primarily due to an increase in claim terminations driven mostly by higher mortality and favorable development on IBNR claims. These decreases were partially offset by aging of the in-force block and higher incremental reserves of $133 million recorded in connection with an accrual for profits followed by losses. In addition, we increased claim reserves by $67 million reflecting our assumption that COVID-19 accelerated our mortality experience on the most vulnerable claimants, leaving the remaining claim population less likely to terminate compared to the pre-pandemic average population. Given our assumption that COVID-19 has temporarily decreased the number of new claims submitted, IBNR reserves were also strengthened by $29 million, partially offsetting the favorable development on IBNR claims. |
• | Our life insurance business decreased $20 million primarily attributable to higher reserves recorded in the prior year on our 10-year term universal life insurance block which entered its post-level premium period, partially offset by higher mortality in our universal and term universal life insurance products in the current year compared to the prior year. |
• | Our fixed annuities business decreased $23 million principally from lower reserves in our fixed indexed annuities driven by favorable equity market and interest rate changes in the current year compared to an unfavorable market in the prior year and higher mortality in our single premium immediate annuities in the current year. |
• | Our life insurance business decreased $3 million principally from prior year lapses in the large 20-year term life insurance block written in 2000, partially offset by a DAC impairment of $22 million in our universal life insurance products largely due to lower future estimated gross profits. |
• | Our fixed annuities business decreased $16 million primarily related to lower DAC amortization reflecting the impact of favorable market changes in the current year. |
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Net earned premiums: |
||||||||||||||||
Individual long-term care insurance |
$ | 615 | $ | 611 | $ | 4 | 1 | % | ||||||||
Group long-term care insurance |
31 | 31 | — | — | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total |
$ | 646 | $ | 642 | $ | 4 | 1 | % | ||||||||
|
|
|
|
|
|
|||||||||||
Loss ratio |
62 | % | 78 | % | (16 | )% |
As of or for the three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Term and whole life insurance |
||||||||||||||||
Net earned premiums |
$ | 68 | $ | 76 | $ | (8 | ) | (11 | )% | |||||||
Life insurance in-force, net of reinsurance |
58,168 | 75,992 | (17,824 | ) | (23 | )% | ||||||||||
Life insurance in-force before reinsurance |
355,424 | 389,553 | (34,129 | ) | (9 | )% | ||||||||||
Term universal life insurance |
||||||||||||||||
Net deposits |
$ | 53 | $ | 56 | $ | (3 | ) | (5 | )% | |||||||
Life insurance in-force, net of reinsurance |
105,360 | 111,945 | (6,585 | ) | (6 | )% | ||||||||||
Life insurance in-force before reinsurance |
106,055 | 112,710 | (6,655 | ) | (6 | )% | ||||||||||
Universal life insurance |
||||||||||||||||
Net deposits |
$ | 69 | $ | 71 | $ | (2 | ) | (3 | )% | |||||||
Life insurance in-force, net of reinsurance |
32,132 | 33,552 | (1,420 | ) | (4 | )% | ||||||||||
Life insurance in-force before reinsurance |
36,435 | 38,144 | (1,709 | ) | (4 | )% | ||||||||||
Total life insurance |
||||||||||||||||
Net earned premiums and deposits |
$ | 190 | $ | 203 | $ | (13 | ) | (6 | )% | |||||||
Life insurance in-force, net of reinsurance |
195,660 | 221,489 | (25,829 | ) | (12 | )% | ||||||||||
Life insurance in-force before reinsurance |
497,914 | 540,407 | (42,493 | ) | (8 | )% |
As of or for the three months ended March 31, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Account value, beginning of period |
$ | 11,815 | $ | 13,023 | ||||
Deposits |
17 | 22 | ||||||
Surrenders, benefits and product charges |
(544 | ) | (467 | ) | ||||
|
|
|
|
|||||
Net flows |
(527 | ) | (445 | ) | ||||
Interest credited and investment performance |
85 | 61 | ||||||
Effect of accumulated net unrealized investment gains (losses) |
(201 | ) | (152 | ) | ||||
|
|
|
|
|||||
Account value, end of period |
$ | 11,172 | $ | 12,487 | ||||
|
|
|
|
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Revenues: |
||||||||||||||||
Net investment income |
$ | 49 | $ | 49 | $ | — | — | % | ||||||||
Net investment gains (losses) |
(6 | ) | (75 | ) | 69 | 92 | % | |||||||||
Policy fees and other income |
33 | 33 | — | — | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
76 | 7 | 69 | NM | (1) | |||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
8 | 20 | (12 | ) | (60 | )% | ||||||||||
Interest credited |
41 | 41 | — | — | % | |||||||||||
Acquisition and operating expenses, net of deferrals |
13 | 13 | — | — | % | |||||||||||
Amortization of deferred acquisition costs and intangibles |
5 | 17 | (12 | ) | (71 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
67 | 91 | (24 | ) | (26 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income (loss) from continuing operations before income taxes |
9 | (84 | ) | 93 | 111 | % | ||||||||||
Provision (benefit) for income taxes |
1 | (18 | ) | 19 | 106 | % | ||||||||||
|
|
|
|
|
|
|||||||||||
Income (loss) from continuing operations |
8 | (66 | ) | 74 | 112 | % | ||||||||||
Adjustments to income (loss) from continuing operations: |
||||||||||||||||
Net investment (gains) losses, net (2) |
5 | 67 | (62 | ) | (93 | )% | ||||||||||
Taxes on adjustments |
(1 | ) | (14 | ) | 13 | 93 | % | |||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | 12 | $ | (13 | ) | $ | 25 | 192 | % | |||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
(2) |
For the three months ended March 31, 2021 and 2020, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(1) million and $(8) million, respectively. |
As of or for the three months ended March 31, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Account value, beginning of period |
$ | 5,001 | $ | 5,042 | ||||
Deposits |
6 | 4 | ||||||
Surrenders, benefits and product charges |
(187 | ) | (166 | ) | ||||
|
|
|
|
|||||
Net flows |
(181 | ) | (162 | ) | ||||
Interest credited and investment performance |
43 | (359 | ) | |||||
|
|
|
|
|||||
Account value, end of period |
$ | 4,863 | $ | 4,521 | ||||
|
|
|
|
As of or for the three months ended March 31, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Funding Agreements |
||||||||
Account value, beginning of period |
$ | 300 | $ | 253 | ||||
Surrenders and benefits |
— | (1 | ) | |||||
|
|
|
|
|||||
Net flows |
— | (1 | ) | |||||
Interest credited |
— | 1 | ||||||
|
|
|
|
|||||
Account value, end of period |
$ | 300 | $ | 253 | ||||
|
|
|
|
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 2 | $ | 2 | $ | — | — | % | ||||||||
Net investment income |
1 | 5 | (4 | ) | (80 | )% | ||||||||||
Net investment gains (losses) |
(2 | ) | 46 | (48 | ) | (104 | )% | |||||||||
Policy fees and other income |
— | 1 | (1 | ) | (100 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
1 | 54 | (53 | ) | (98 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
— | 1 | (1 | ) | (100 | )% | ||||||||||
Acquisition and operating expenses, net of deferrals |
13 | 23 | (10 | ) | (43 | )% | ||||||||||
Interest expense |
38 | 46 | (8 | ) | (17 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
51 | 70 | (19 | ) | (27 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Loss from continuing operations before income taxes |
(50 | ) | (16 | ) | (34 | ) | NM | (1) | ||||||||
Benefit for income taxes |
(8 | ) | — | (8 | ) | NM | (1) | |||||||||
|
|
|
|
|
|
|||||||||||
Loss from continuing operations |
(42 | ) | (16 | ) | (26 | ) | (163 | )% | ||||||||
Adjustments to loss from continuing operations: |
||||||||||||||||
Net investment (gains) losses |
2 | (46 | ) | 48 | 104 | % | ||||||||||
(Gains) losses on early extinguishment of debt |
4 | 8 | (4 | ) | (50 | )% | ||||||||||
Expenses related to restructuring |
7 | 1 | 6 | NM | (1) | |||||||||||
Taxes on adjustments |
(3 | ) | 8 | (11 | ) | (138 | )% | |||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders |
$ | (32 | ) | $ | (45 | ) | $ | 13 | 29 | % | ||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
Three months ended March 31, |
Increase (decrease) |
|||||||||||||||||||||||
2021 |
2020 |
2021 vs. 2020 |
||||||||||||||||||||||
(Amounts in millions) |
Yield |
Amount |
Yield |
Amount |
Yield |
Amount |
||||||||||||||||||
Fixed maturity securities—taxable |
4.5 | % | $ | 599 | 4.7 | % | $ | 611 | (0.2 | )% | $ | (12 | ) | |||||||||||
Fixed maturity securities—non-taxable |
6.3 | % | 2 | 5.2 | % | 2 | 1.1 | % | — | |||||||||||||||
Equity securities |
3.8 | % | 3 | 4.8 | % | 2 | (1.0 | )% | 1 | |||||||||||||||
Commercial mortgage loans |
4.6 | % | 78 | 4.9 | % | 85 | (0.3 | )% | (7 | ) | ||||||||||||||
Policy loans |
10.1 | % | 50 | 9.5 | % | 49 | 0.6 | % | 1 | |||||||||||||||
Other invested assets (1) |
24.4 | % | 89 | 17.8 | % | 47 | 6.6 | % | 42 | |||||||||||||||
Cash, cash equivalents, restricted cash and short-term investments |
— | % | — | 1.4 | % | 10 | (1.4 | )% | (10 | ) | ||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Gross investment income before expenses and fees |
5.0 | % | 821 | 4.9 | % | 806 | 0.1 | % | 15 | |||||||||||||||
Expenses and fees |
(0.2 | )% | (20 | ) | (0.1 | )% | (24 | ) | (0.1 | )% | 4 | |||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Net investment income |
4.8 | % | $ | 801 | 4.8 | % | $ | 782 | — | % | $ | 19 | ||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Average invested assets and cash |
$ | 66,233 | $ | 65,269 | $ | 964 | ||||||||||||||||||
|
|
|
|
|
|
(1) |
Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation and includes limited partnership investments, which are primarily equity-based and do not have fixed returns by period. |
Three months ended March 31, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Available-for-sale |
||||||||
Realized gains |
$ | 7 | $ | 2 | ||||
Realized losses |
(3 | ) | — | |||||
|
|
|
|
|||||
Net realized gains (losses) on available-for-sale |
4 | 2 | ||||||
|
|
|
|
|||||
Net change in allowance for credit losses on available-for-sale |
(2 | ) | — | |||||
Write-down of available-for-sale |
(1 | ) | — | |||||
Net realized gains (losses) on equity securities sold |
(5 | ) | — | |||||
Net unrealized gains (losses) on equity securities still held |
(8 | ) | (12 | ) | ||||
Limited partnerships |
37 | (40 | ) | |||||
Commercial mortgage loans |
(1 | ) | — | |||||
Derivative instruments |
8 | (48 | ) | |||||
Other |
1 | (1 | ) | |||||
|
|
|
|
|||||
Net investment gains (losses) |
$ | 33 | $ | (99 | ) | |||
|
|
|
|
• | We had $37 million of net gains on limited partnership investments during the three months ended March 31, 2021 compared to $40 million of net losses during the three months ended March 31, 2020 primarily from net unrealized gains driven by favorable private equity performance in the current year compared to unfavorable private equity performance in the prior year. |
• | We recorded net gains related to derivatives of $8 million during the three months ended March 31, 2021 primarily associated with hedging programs that support our indexed universal life insurance and fixed indexed annuity products, partially offset by losses from hedging programs that support our runoff variable annuity products. |
March 31, 2021 |
December 31, 2020 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Fixed maturity securities, available-for-sale: |
||||||||||||||||
Public |
$ | 42,029 | 58 | % | $ | 44,776 | 58 | % | ||||||||
Private |
18,202 | 25 | 18,719 | 24 | ||||||||||||
Equity securities |
238 | — | 386 | — | ||||||||||||
Commercial mortgage loans, net |
6,755 | 9 | 6,743 | 9 | ||||||||||||
Policy loans |
1,976 | 3 | 1,978 | 3 | ||||||||||||
Other invested assets |
1,759 | 2 | 2,099 | 3 | ||||||||||||
Cash, cash equivalents and restricted cash |
1,964 | 3 | 2,561 | 3 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash, cash equivalents, restricted cash and invested assets |
$ | 72,923 | 100 | % | $ | 77,262 | 100 | % | ||||||||
|
|
|
|
|
|
|
|
(Amounts in millions) |
Amortized cost or cost |
Gross unrealized gains |
Gross unrealized losses |
Allowance for credit losses |
Fair value |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | 3,323 | $ | 951 | $ | (1 | ) | $ | — | $ | 4,273 | |||||||||
State and political subdivisions |
2,762 | 384 | (11 | ) | — | 3,135 | ||||||||||||||
Non-U.S. government |
749 | 84 | (13 | ) | — | 820 | ||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
4,242 | 644 | (13 | ) | — | 4,873 | ||||||||||||||
Energy |
2,551 | 275 | (24 | ) | — | 2,802 | ||||||||||||||
Finance and insurance |
7,785 | 879 | (45 | ) | — | 8,619 | ||||||||||||||
Consumer—non-cyclical |
5,173 | 904 | (11 | ) | — | 6,066 | ||||||||||||||
Technology and communications |
3,254 | 419 | (16 | ) | — | 3,657 | ||||||||||||||
Industrial |
1,366 | 159 | (4 | ) | — | 1,521 | ||||||||||||||
Capital goods |
2,476 | 377 | (8 | ) | — | 2,845 | ||||||||||||||
Consumer—cyclical |
1,740 | 198 | (8 | ) | — | 1,930 | ||||||||||||||
Transportation |
1,171 | 200 | (1 | ) | — | 1,370 | ||||||||||||||
Other |
393 | 32 | (1 | ) | — | 424 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total U.S. corporate |
30,151 | 4,087 | (131 | ) | — | 34,107 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
895 | 64 | (2 | ) | — | 957 | ||||||||||||||
Energy |
1,164 | 167 | (4 | ) | — | 1,327 | ||||||||||||||
Finance and insurance |
2,193 | 263 | (22 | ) | (3 | ) | 2,431 | |||||||||||||
Consumer—non-cyclical |
661 | 65 | (4 | ) | — | 722 | ||||||||||||||
Technology and communications |
1,062 | 146 | (1 | ) | — | 1,207 | ||||||||||||||
Industrial |
1,018 | 118 | (2 | ) | — | 1,134 | ||||||||||||||
Capital goods |
537 | 48 | (3 | ) | — | 582 | ||||||||||||||
Consumer—cyclical |
356 | 27 | (2 | ) | — | 381 | ||||||||||||||
Transportation |
459 | 67 | (1 | ) | — | 525 | ||||||||||||||
Other |
1,054 | 166 | (1 | ) | — | 1,219 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total non-U.S. corporate |
9,399 | 1,131 | (42 | ) | (3 | ) | 10,485 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Residential mortgage-backed (1) |
1,600 | 175 | (1 | ) | — | 1,774 | ||||||||||||||
Commercial mortgage-backed |
2,688 | 121 | (15 | ) | — | 2,794 | ||||||||||||||
Other asset-backed |
2,798 | 48 | (3 | ) | — | 2,843 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total available-for-sale |
$ | 53,470 | $ | 6,981 | $ | (217 | ) | $ | (3 | ) | $ | 60,231 | ||||||||
|
|
|
|
|
|
|
|
|
|
(1) |
Fair value included $7 million collateralized by Alt-A residential mortgage loans. |
(Amounts in millions) |
Amortized cost or cost |
Gross unrealized gains |
Gross unrealized losses |
Allowance for credit losses |
Fair value |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | 3,401 | $ | 1,404 | $ | — | $ | — | $ | 4,805 | ||||||||||
State and political subdivisions |
2,622 | 544 | (1 | ) | — | 3,165 | ||||||||||||||
Non-U.S. government |
728 | 130 | (4 | ) | — | 854 | ||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
4,226 | 970 | (2 | ) | — | 5,194 | ||||||||||||||
Energy |
2,532 | 367 | (16 | ) | — | 2,883 | ||||||||||||||
Finance and insurance |
7,798 | 1,306 | (2 | ) | — | 9,102 | ||||||||||||||
Consumer—non-cyclical |
5,115 | 1,323 | (1 | ) | — | 6,437 | ||||||||||||||
Technology and communications |
3,142 | 619 | — | — | 3,761 | |||||||||||||||
Industrial |
1,370 | 232 | — | — | 1,602 | |||||||||||||||
Capital goods |
2,456 | 535 | — | — | 2,991 | |||||||||||||||
Consumer—cyclical |
1,663 | 284 | — | — | 1,947 | |||||||||||||||
Transportation |
1,198 | 304 | (2 | ) | — | 1,500 | ||||||||||||||
Other |
395 | 45 | — | — | 440 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total U.S. corporate |
29,895 | 5,985 | (23 | ) | — | 35,857 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
838 | 84 | — | — | 922 | |||||||||||||||
Energy |
1,172 | 209 | (1 | ) | — | 1,380 | ||||||||||||||
Finance and insurance |
2,130 | 353 | (6 | ) | (1 | ) | 2,476 | |||||||||||||
Consumer—non-cyclical |
662 | 112 | (1 | ) | — | 773 | ||||||||||||||
Technology and communications |
1,062 | 229 | — | — | 1,291 | |||||||||||||||
Industrial |
969 | 159 | — | — | 1,128 | |||||||||||||||
Capital goods |
510 | 67 | (1 | ) | — | 576 | ||||||||||||||
Consumer—cyclical |
331 | 41 | (1 | ) | — | 371 | ||||||||||||||
Transportation |
483 | 88 | (1 | ) | — | 570 | ||||||||||||||
Other |
1,088 | 236 | — | — | 1,324 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total non-U.S. corporate |
9,245 | 1,578 | (11 | ) | (1 | ) | 10,811 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Residential mortgage-backed (1) |
1,698 | 211 | — | — | 1,909 | |||||||||||||||
Commercial mortgage-backed |
2,759 | 231 | (13 | ) | (3 | ) | 2,974 | |||||||||||||
Other asset-backed |
3,069 | 55 | (4 | ) | — | 3,120 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total available-for-sale |
$ | 53,417 | $ | 10,138 | $ | (56 | ) | $ | (4 | ) | $ | 63,495 | ||||||||
|
|
|
|
|
|
|
|
|
|
(1) |
Fair value included $8 million collateralized by Alt-A residential mortgage loans. |
March 31, 2021 |
December 31, 2020 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Limited partnerships |
$ | 1,160 | 66 | % | $ | 1,049 | 50 | % | ||||||||
Bank loan investments |
331 | 19 | 344 | 16 | ||||||||||||
Derivatives |
164 | 9 | 574 | 28 | ||||||||||||
Securities lending collateral |
68 | 4 | 67 | 3 | ||||||||||||
Short-term investments |
17 | 1 | 45 | 2 | ||||||||||||
Other investments |
19 | 1 | 20 | 1 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total other invested assets |
$ | 1,759 | 100 | % | $ | 2,099 | 100 | % | ||||||||
|
|
|
|
|
|
|
|
(Notional in millions) |
Measurement |
December 31, 2020 |
Additions |
Maturities/ terminations |
March 31, 2021 |
|||||||||||||||
Derivatives designated as hedges |
||||||||||||||||||||
Cash flow hedges: |
||||||||||||||||||||
Interest rate swaps |
Notional | $ | 8,178 | $ | — | $ | (52 | ) | $ | 8,126 | ||||||||||
Foreign currency swaps |
Notional | 127 | — | — | 127 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total cash flow hedges |
8,305 | — | (52 | ) | 8,253 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives designated as hedges |
8,305 | — | (52 | ) | 8,253 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||
Interest rate swaps |
Notional | 4,674 | — | — | 4,674 | |||||||||||||||
Equity index options |
Notional | 2,000 | 352 | (432 | ) | 1,920 | ||||||||||||||
Financial futures |
Notional | 1,104 | 1,008 | (1,114 | ) | 998 | ||||||||||||||
Other foreign currency contracts |
Notional | 1,186 | 12 | (495 | ) | 703 | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives not designated as hedges |
8,964 | 1,372 | (2,041 | ) | 8,295 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives |
$ | 17,269 | $ | 1,372 | $ | (2,093 | ) | $ | 16,548 | |||||||||||
|
|
|
|
|
|
|
|
(Number of policies) |
Measurement |
December 31, 2020 |
Additions |
Maturities/ terminations |
March 31, 2021 |
|||||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||
GMWB embedded derivatives |
Policies | 23,713 | — | (536 | ) | 23,177 | ||||||||||||||
Fixed index annuity embedded derivatives |
Policies | 12,778 | — | (1,010 | ) | 11,768 | ||||||||||||||
Indexed universal life embedded derivatives |
Policies | 842 | — | (8 | ) | 834 |
• | Cash, cash equivalents, restricted cash and invested assets decreased $4,339 million primarily from decreases of $3,264 million, $597 million and $340 million in fixed maturity securities, cash, cash equivalents, restricted cash and other invested assets, respectively. The decrease in fixed maturity securities was predominantly related to a decrease in unrealized gains due to an increase in interest rates in the current year. The decrease in cash, cash equivalents and restricted cash was largely related to the redemption of $338 million of Genworth Holdings’ senior notes that matured in February 2021, payments made to AXA of $247 million under the promissory note and the repurchase of $146 million principal amount of senior notes in the current year that are due in September 2021. These decreases to cash were partially offset by net proceeds of approximately $370 million received from the sale of Genworth Australia and from net sales of investment securities in the current year. The decrease in other invested assets was principally from lower derivative valuations due to an increase in interest rates, partially offset by additional capital investments in limited partnerships in the current year. |
• | DAC decreased $240 million principally attributable to shadow accounting adjustments associated with a decrease in unrealized gains in the current year. The shadow accounting adjustments decreased DAC by approximately $174 million, mostly in our term universal life insurance product, with an offsetting amount recorded in other comprehensive income (loss). The decrease was also attributable to higher amortization largely driven by an increase in lapses in our term life insurance blocks and amortization outpacing deferrals reflecting the low sales in our long-term care insurance business. In connection with a DAC recoverability review, we also wrote off $22 million of DAC in our universal life insurance products in the current year due principally to lower future estimated gross profits. |
• | Deferred tax asset increased $249 million largely due to a decrease in unrealized gains on derivatives and investments and from a deferred tax asset of $89 million recorded on the loss on sale of Genworth Australia, partially offset by the utilization of net operating losses and foreign tax credits in the current year. |
• | Assets related to discontinued operations decreased $2,817 million due to the sale and deconsolidation of Genworth Australia in the current year. |
• | Future policy benefits decreased $2,061 million primarily driven by shadow accounting adjustments associated with a decrease in unrealized gains in the current year. The shadow accounting adjustments decreased future policy benefits by approximately $2,194 million, mostly in our long-term care insurance business, with an offsetting amount recorded in other comprehensive income (loss). The decrease was also attributable to reduced benefits of $154 million in the current year related to in-force actions approved and implemented in our long-term care insurance business, net outflows driven by surrenders and benefits in our single premium immediate annuity products and from the runoff of our term life insurance products, including from higher lapses in the current year. These decreases were partially offset by aging of our long-term care insurance in-force block and higher incremental reserves of $174 million recorded in connection with an accrual for profits followed by losses in the current year. |
• | Policyholder account balances decreased $1,504 million largely attributable to shadow accounting adjustments associated with a decrease in unrealized gains in the current year. The shadow accounting adjustments decreased policyholder account balances by approximately $950 million, mostly in our universal life insurance products, with an offsetting amount recorded in other comprehensive income (loss). The decrease was also related to surrenders and benefits in our single premium deferred annuity products in the current year. |
• | Liability for policy and contract claims decreased $71 million largely related to lower claim severity and higher claim payments in our life insurance business in the current year. The decrease was also attributable to our long-term care insurance business primarily attributable to higher claim terminations, partially offset by higher new claims and claim severity as a result of the aging of the in-force block and a $67 million increase to claim reserves, reflecting our assumption that COVID-19 has accelerated mortality experience on the most vulnerable claimants, leaving the remaining claim population less likely to terminate compared to the pre-pandemic average population. These decreases were partially offset by our U.S. mortgage insurance business largely due to new delinquencies driven largely by borrower forbearance resulting from COVID-19. |
• | Long-term borrowings decreased $481 million mainly attributable to the redemption of Genworth Holdings’ 7.20% senior notes due in February 2021 and the repurchase of $146 million principal amount of its senior notes with a September 2021 maturity date in the current year. |
• | Liabilities related to discontinued operations decreased $2,010 million predominantly from the sale and deconsolidation of Genworth Australia, which also resulted in a mandatory payment of approximately $247 million, including accrued interest, to AXA under the secured promissory note in the current year. |
• | We reported net income available to Genworth Financial, Inc.’s common stockholders of $187 million for the three months ended March 31, 2021. |
• | Derivatives qualifying as hedges and unrealized gains on investments decreased $419 million and $295 million, respectively, primarily from an increase in interest rates in the current year. |
• | Noncontrolling interests decreased $502 million related to the deconsolidation of the ownership interest attributable to noncontrolling interests of Genworth Australia recorded in connection with the final disposition in March 2021. |
(Amounts in millions) |
2021 |
2020 |
||||||
Net cash from (used by) operating activities |
$ | (247 | ) | $ | 680 | |||
Net cash from (used by) investing activities |
335 | (551 | ) | |||||
Net cash used by financing activities |
(780 | ) | (957 | ) | ||||
|
|
|
|
|||||
Net decrease in cash before foreign exchange effect |
$ | (692 | ) | $ | (828 | ) | ||
|
|
|
|
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities available-for-sale, |
$ | — | $ | — | $ | 60,231 | $ | — | $ | 60,231 | ||||||||||
Equity securities, at fair value |
— | — | 238 | — | 238 | |||||||||||||||
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $4) |
— | — | 6,787 | — | 6,787 | |||||||||||||||
Less: Allowance for credit losses |
— | — | (32 | ) | — | (32 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Commercial mortgage loans, net |
— | — | 6,755 | — | 6,755 | |||||||||||||||
Policy loans |
— | — | 1,976 | — | 1,976 | |||||||||||||||
Other invested assets |
— | 26 | 1,733 | — | 1,759 | |||||||||||||||
Investments in subsidiaries |
14,783 | 15,672 | — | (30,455 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total investments |
14,783 | 15,698 | 70,933 | (30,455 | ) | 70,959 | ||||||||||||||
Cash, cash equivalents and restricted cash |
— | 757 | 1,207 | — | 1,964 | |||||||||||||||
Accrued investment income |
— | — | 704 | — | 704 | |||||||||||||||
Deferred acquisition costs |
— | — | 1,247 | — | 1,247 | |||||||||||||||
Intangible assets |
— | — | 155 | — | 155 | |||||||||||||||
Reinsurance recoverable |
— | — | 16,788 | — | 16,788 | |||||||||||||||
Less: Allowance for credit losses |
— | — | (44 | ) | — | (44 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Reinsurance recoverable, net |
— | — | 16,744 | — | 16,744 | |||||||||||||||
Other assets |
— | 146 | 293 | — | 439 | |||||||||||||||
Intercompany notes receivable |
— | 98 | — | (98 | ) | — | ||||||||||||||
Deferred tax assets |
3 | 713 | (402 | ) | — | 314 | ||||||||||||||
Separate account assets |
— | — | 6,032 | — | 6,032 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total assets |
$ | 14,786 | $ | 17,412 | $ | 96,913 | $ | (30,553 | ) | $ | 98,558 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Liabilities and equity |
||||||||||||||||||||
Liabilities: |
||||||||||||||||||||
Future policy benefits |
$ | — | $ | — | $ | 40,634 | $ | — | $ | 40,634 | ||||||||||
Policyholder account balances |
— | — | 19,999 | — | 19,999 | |||||||||||||||
Liability for policy and contract claims |
— | — | 11,415 | — | 11,415 | |||||||||||||||
Unearned premiums |
— | — | 728 | — | 728 | |||||||||||||||
Other liabilities |
5 | 117 | 1,588 | — | 1,710 | |||||||||||||||
Intercompany notes payable |
23 | — | 75 | (98 | ) | — | ||||||||||||||
Long-term borrowings |
— | 2,183 | 739 | — | 2,922 | |||||||||||||||
Separate account liabilities |
— | — | 6,032 | — | 6,032 | |||||||||||||||
Liabilities related to discontinued operations |
— | 339 | 21 | — | 360 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities |
28 | 2,639 | 81,231 | (98 | ) | 83,800 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Equity: |
||||||||||||||||||||
Common stock |
1 | — | 3 | (3 | ) | 1 | ||||||||||||||
Additional paid-in capital |
12,011 | 12,890 | 18,561 | (31,451 | ) | 12,011 | ||||||||||||||
Accumulated other comprehensive income (loss) |
3,675 | 3,675 | 3,717 | (7,392 | ) | 3,675 | ||||||||||||||
Retained earnings |
1,771 | (1,792 | ) | (6,899 | ) | 8,691 | 1,771 | |||||||||||||
Treasury stock, at cost |
(2,700 | ) | — | — | — | (2,700 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Genworth Financial, Inc.’s stockholders’ equity |
14,758 | 14,773 | 15,382 | (30,155 | ) | 14,758 | ||||||||||||||
Noncontrolling interests |
— | — | 300 | (300 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total equity |
14,758 | 14,773 | 15,682 | (30,455 | ) | 14,758 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities and equity |
$ | 14,786 | $ | 17,412 | $ | 96,913 | $ | (30,553 | ) | $ | 98,558 | |||||||||
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities available-for-sale, |
$ | — | $ | — | $ | 63,495 | $ | — | $ | 63,495 | ||||||||||
Equity securities, at fair value |
— | — | 386 | — | 386 | |||||||||||||||
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $4) |
— | — | 6,774 | — | 6,774 | |||||||||||||||
Less: Allowance for credit losses |
— | — | (31 | ) | — | (31 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Commercial mortgage loans, net |
— | — | 6,743 | — | 6,743 | |||||||||||||||
Policy loans |
— | — | 1,978 | — | 1,978 | |||||||||||||||
Other invested assets |
— | 67 | 2,032 | — | 2,099 | |||||||||||||||
Investments in subsidiaries |
15,358 | 16,673 | — | (32,031 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total investments |
15,358 | 16,740 | 74,634 | (32,031 | ) | 74,701 | ||||||||||||||
Cash, cash equivalents and restricted cash |
— | 1,078 | 1,483 | — | 2,561 | |||||||||||||||
Accrued investment income |
— | — | 655 | — | 655 | |||||||||||||||
Deferred acquisition costs |
— | — | 1,487 | — | 1,487 | |||||||||||||||
Intangible assets |
— | — | 157 | — | 157 | |||||||||||||||
Reinsurance recoverable |
— | — | 16,864 | — | 16,864 | |||||||||||||||
Less: Allowance for credit losses |
— | — | (45 | ) | — | (45 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Reinsurance recoverable, net |
— | — | 16,819 | — | 16,819 | |||||||||||||||
Other assets |
2 | 146 | 256 | — | 404 | |||||||||||||||
Intercompany notes receivable |
— | 19 | — | (19 | ) | — | ||||||||||||||
Deferred tax assets |
13 | 767 | (715 | ) | — | 65 | ||||||||||||||
Separate account assets |
— | — | 6,081 | — | 6,081 | |||||||||||||||
Assets related to discontinued operations |
— | — | 2,817 | — | 2,817 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total assets |
$ | 15,373 | $ | 18,750 | $ | 103,674 | $ | (32,050 | ) | $ | 105,747 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Liabilities and equity |
||||||||||||||||||||
Liabilities: |
||||||||||||||||||||
Future policy benefits |
$ | — | $ | — | $ | 42,695 | $ | — | $ | 42,695 | ||||||||||
Policyholder account balances |
— | — | 21,503 | — | 21,503 | |||||||||||||||
Liability for policy and contract claims |
— | — | 11,486 | — | 11,486 | |||||||||||||||
Unearned premiums |
— | — | 775 | — | 775 | |||||||||||||||
Other liabilities |
55 | 156 | 1,403 | — | 1,614 | |||||||||||||||
Intercompany notes payable |
— | — | 19 | (19 | ) | — | ||||||||||||||
Long-term borrowings |
— | 2,665 | 738 | — | 3,403 | |||||||||||||||
Separate account liabilities |
— | — | 6,081 | — | 6,081 | |||||||||||||||
Liabilities related to discontinued operations |
— | 581 | 1,789 | — | 2,370 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities |
55 | 3,402 | 86,489 | (19 | ) | 89,927 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Equity: |
||||||||||||||||||||
Common stock |
1 | — | 3 | (3 | ) | 1 | ||||||||||||||
Additional paid-in capital |
12,008 | 12,890 | 18,562 | (31,452 | ) | 12,008 | ||||||||||||||
Accumulated other comprehensive income (loss) |
4,425 | 4,426 | 4,499 | (8,925 | ) | 4,425 | ||||||||||||||
Retained earnings |
1,584 | (1,968 | ) | (6,681 | ) | 8,649 | 1,584 | |||||||||||||
Treasury stock, at cost |
(2,700 | ) | — | — | — | (2,700 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Genworth Financial, Inc.’s stockholders’ equity |
15,318 | 15,348 | 16,383 | (31,731 | ) | 15,318 | ||||||||||||||
Noncontrolling interests |
— | — | 802 | (300 | ) | 502 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total equity |
15,318 | 15,348 | 17,185 | (32,031 | ) | 15,820 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities and equity |
$ | 15,373 | $ | 18,750 | $ | 103,674 | $ | (32,050 | ) | $ | 105,747 | |||||||||
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Revenues: |
||||||||||||||||||||
Premiums |
$ | — | $ | — | $ | 968 | $ | — | $ | 968 | ||||||||||
Net investment income |
(1 | ) | — | 802 | — | 801 | ||||||||||||||
Net investment gains (losses) |
— | — | 33 | — | 33 | |||||||||||||||
Policy fees and other income |
— | (1 | ) | 182 | 2 | 183 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total revenues |
(1 | ) | (1 | ) | 1,985 | 2 | 1,985 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||||||
Benefits and other changes in policy reserves |
— | — | 1,218 | — | 1,218 | |||||||||||||||
Interest credited |
— | — | 131 | — | 131 | |||||||||||||||
Acquisition and operating expenses, net of deferrals |
6 | 4 | 265 | — | 275 | |||||||||||||||
Amortization of deferred acquisition costs and intangibles |
— | — | 77 | — | 77 | |||||||||||||||
Interest expense |
— | 37 | 12 | 2 | 51 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
6 | 41 | 1,703 | 2 | 1,752 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries |
(7 | ) | (42 | ) | 282 | — | 233 | |||||||||||||
Provision (benefit) for income taxes |
2 | (9 | ) | 66 | — | 59 | ||||||||||||||
Equity in income of subsidiaries |
196 | 189 | — | (385 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
187 | 156 | 216 | (385 | ) | 174 | ||||||||||||||
Income (loss) from discontinued operations, net of taxes |
— | 40 | (19 | ) | — | 21 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income |
187 | 196 | 197 | (385 | ) | 195 | ||||||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
— | — | — | — | — | |||||||||||||||
Less: net income from discontinued operations attributable to noncontrolling interests |
— | — | 8 | — | 8 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | 187 | $ | 196 | $ | 189 | $ | (385 | ) | $ | 187 | |||||||||
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Revenues: |
||||||||||||||||||||
Premiums |
$ | — | $ | — | $ | 3,836 | $ | — | $ | 3,836 | ||||||||||
Net investment income |
(3 | ) | 5 | 3,228 | (3 | ) | 3,227 | |||||||||||||
Net investment gains (losses) |
— | 6 | 486 | — | 492 | |||||||||||||||
Policy fees and other income |
— | 3 | 730 | (4 | ) | 729 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total revenues |
(3 | ) | 14 | 8,280 | (7 | ) | 8,284 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||||||
Benefits and other changes in policy reserves |
— | — | 5,214 | — | 5,214 | |||||||||||||||
Interest credited |
— | — | 549 | — | 549 | |||||||||||||||
Acquisition and operating expenses, net of deferrals |
31 | 6 | 898 | — | 935 | |||||||||||||||
Amortization of deferred acquisition costs and intangibles |
— | — | 463 | — | 463 | |||||||||||||||
Interest expense |
1 | 175 | 26 | (7 | ) | 195 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
32 | 181 | 7,150 | (7 | ) | 7,356 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries |
(35 | ) | (167 | ) | 1,130 | — | 928 | |||||||||||||
Provision (benefit) for income taxes |
(2 | ) | (41 | ) | 273 | — | 230 | |||||||||||||
Equity in income of subsidiaries |
210 | 912 | — | (1,122 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
177 | 786 | 857 | (1,122 | ) | 698 | ||||||||||||||
Income (loss) from discontinued operations, net of taxes |
1 | (573 | ) | 86 | — | (486 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income |
178 | 213 | 943 | (1,122 | ) | 212 | ||||||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
— | — | — | — | — | |||||||||||||||
Less: net income from discontinued operations attributable to noncontrolling interests |
— | — | 34 | — | 34 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | 178 | $ | 213 | $ | 909 | $ | (1,122 | ) | $ | 178 | |||||||||
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Net income |
$ | 187 | $ | 196 | $ | 197 | $ | (385 | ) | $ | 195 | |||||||||
Other comprehensive income (loss), net of taxes: |
||||||||||||||||||||
Net unrealized gains (losses) on securities without an allowance for credit losses |
(297 | ) | (298 | ) | (323 | ) | 596 | (322 | ) | |||||||||||
Net unrealized gains (losses) on securities with an allowance for credit losses |
2 | 2 | 2 | (4 | ) | 2 | ||||||||||||||
Derivatives qualifying as hedges |
(419 | ) | (419 | ) | (452 | ) | 871 | (419 | ) | |||||||||||
Foreign currency translation and other adjustments |
(36 | ) | (36 | ) | 138 | 70 | 136 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total other comprehensive income (loss) |
(750 | ) | (751 | ) | (635 | ) | 1,533 | (603 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total comprehensive loss |
(563 | ) | (555 | ) | (438 | ) | 1,148 | (408 | ) | |||||||||||
Less: comprehensive income attributable to noncontrolling interests |
— | — | 155 | — | 155 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total comprehensive loss available to Genworth Financial, Inc.’s common stockholders |
$ | (563 | ) | $ | (555 | ) | $ | (593 | ) | $ | 1,148 | $ | (563 | ) | ||||||
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Net income |
$ | 178 | $ | 213 | $ | 943 | $ | (1,122 | ) | $ | 212 | |||||||||
Other comprehensive income (loss), net of taxes: |
||||||||||||||||||||
Net unrealized gains (losses) on securities without an allowance for credit losses |
764 | 765 | 765 | (1,530 | ) | 764 | ||||||||||||||
Net unrealized gains (losses) on securities with an allowance for credit losses |
(6 | ) | (6 | ) | (6 | ) | 12 | (6 | ) | |||||||||||
Derivatives qualifying as hedges |
209 | 209 | 241 | (450 | ) | 209 | ||||||||||||||
Foreign currency translation and other adjustments |
25 | 25 | 55 | (50 | ) | 55 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total other comprehensive income (loss) |
992 | 993 | 1,055 | (2,018 | ) | 1,022 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total comprehensive income |
1,170 | 1,206 | 1,998 | (3,140 | ) | 1,234 | ||||||||||||||
Less: comprehensive income attributable to noncontrolling interests |
— | — | 64 | — | 64 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total comprehensive income available to Genworth Financial, Inc.’s common stockholders |
$ | 1,170 | $ | 1,206 | $ | 1,934 | $ | (3,140 | ) | $ | 1,170 | |||||||||
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Cash flows from (used by) operating activities: |
||||||||||||||||||||
Net income |
$ | 187 | $ | 196 | $ | 197 | $ | (385 | ) | $ | 195 | |||||||||
Less (income) loss from discontinued operations, net of taxes |
— | (40 | ) | 19 | — | (21 | ) | |||||||||||||
Adjustments to reconcile net income to net cash from (used by) operating activities: |
||||||||||||||||||||
Equity in income from subsidiaries |
(196 | ) | (189 | ) | — | 385 | — | |||||||||||||
Dividends from subsidiaries |
— | 370 | (370 | ) | — | — | ||||||||||||||
Amortization of fixed maturity securities discounts and premiums |
— | 1 | (33 | ) | — | (32 | ) | |||||||||||||
Net investment (gains) losses |
— | — | (33 | ) | — | (33 | ) | |||||||||||||
Charges assessed to policyholders |
— | — | (159 | ) | — | (159 | ) | |||||||||||||
Acquisition costs deferred |
— | — | (2 | ) | — | (2 | ) | |||||||||||||
Amortization of deferred acquisition costs and intangibles |
— | — | 77 | — | 77 | |||||||||||||||
Deferred income taxes |
5 | 70 | (15 | ) | — | 59 | ||||||||||||||
Derivative instruments, limited partnerships and other |
— | 58 | (171 | ) | — | (113 | ) | |||||||||||||
Stock-based compensation expense |
11 | — | — | — | 11 | |||||||||||||||
Change in certain assets and liabilities: |
||||||||||||||||||||
Accrued investment income and other assets |
2 | 9 | (69 | ) | — | (58 | ) | |||||||||||||
Insurance reserves |
— | — | 326 | — | 326 | |||||||||||||||
Current tax liabilities |
(6 | ) | 14 | (13 | ) | — | (4 | ) | ||||||||||||
Other liabilities, policy and contract claims and other policy-related balances |
(24 | ) | (39 | ) | (256 | ) | — | (319 | ) | |||||||||||
Cash from (used by) operating activities—discontinued operations |
— | (247 | ) | 73 | — | (174 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash from (used by) operating activities |
(21 | ) | 203 | (429 | ) | — | (247 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash flows from (used by) investing activities: |
||||||||||||||||||||
Proceeds from maturities and repayments of investments: |
||||||||||||||||||||
Fixed maturity securities |
— | — | 1,031 | — | 1,031 | |||||||||||||||
Commercial mortgage loans |
— | — | 129 | — | 129 | |||||||||||||||
Other invested assets |
— | — | 44 | — | 44 | |||||||||||||||
Proceeds from sales of investments: |
||||||||||||||||||||
Fixed maturity and equity securities |
— | — | 777 | — | 777 | |||||||||||||||
Purchases and originations of investments: |
||||||||||||||||||||
Fixed maturity and equity securities |
— | — | (1,647 | ) | — | (1,647 | ) | |||||||||||||
Commercial mortgage loans |
— | — | (142 | ) | — | (142 | ) | |||||||||||||
Other invested assets |
— | — | (91 | ) | — | (91 | ) | |||||||||||||
Short-term investments, net |
— | 25 | 3 | — | 28 | |||||||||||||||
Policy loans, net |
— | — | 3 | — | 3 | |||||||||||||||
Intercompany notes receivable |
— | (79 | ) | — | 79 | — | ||||||||||||||
Proceeds from sale of business, net of cash transferred |
— | — | 270 | — | 270 | |||||||||||||||
Cash used by investing activities—discontinued operations |
— | — | (67 | ) | — | (67 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash from (used by) investing activities |
— | (54 | ) | 310 | 79 | 335 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash flows from (used by) financing activities: |
||||||||||||||||||||
Deposits to universal life and investment contracts |
— | — | 176 | — | 176 | |||||||||||||||
Withdrawals from universal life and investment contracts |
— | — | (578 | ) | — | (578 | ) | |||||||||||||
Repayment and repurchase of long-term debt |
— | (470 | ) | — | — | (470 | ) | |||||||||||||
Intercompany notes payable |
23 | — | 56 | (79 | ) | — | ||||||||||||||
Other, net |
(2 | ) | — | 94 | — | 92 | ||||||||||||||
Cash used by financing activities—discontinued operations |
— | — | — | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash from (used by) financing activities |
21 | (470 | ) | (252 | ) | (79 | ) | (780 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $(1) related to discontinued operations) |
— | — | — | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net change in cash, cash equivalents and restricted cash |
— | (321 | ) | (371 | ) | — | (692 | ) | ||||||||||||
Cash, cash equivalents and restricted cash at beginning of period |
— | 1,078 | 1,578 | — | 2,656 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash, cash equivalents and restricted cash at end of period |
— | 757 | 1,207 | — | 1,964 | |||||||||||||||
Less cash, cash equivalents and restricted cash of discontinued operations at end of period |
— | — | — | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash, cash equivalents and restricted cash of continuing operations at end of period |
$ | — | $ | 757 | $ | 1,207 | $ | — | $ | 1,964 | ||||||||||
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Cash flows from operating activities: |
||||||||||||||||||||
Net income |
$ | 178 | $ | 213 | $ | 943 | $ | (1,122 | ) | $ | 212 | |||||||||
Less (income) loss from discontinued operations, net of taxes |
(1 | ) | 573 | (86 | ) | — | 486 | |||||||||||||
Adjustments to reconcile net income to net cash from operating activities: |
||||||||||||||||||||
Equity in income from subsidiaries |
(210 | ) | (912 | ) | — | 1,122 | — | |||||||||||||
Dividends from subsidiaries |
— | 437 | (437 | ) | — | — | ||||||||||||||
Amortization of fixed maturity securities discounts and premiums |
— | 6 | (163 | ) | — | (157 | ) | |||||||||||||
Net investment (gains) losses |
— | (6 | ) | (486 | ) | — | (492 | ) | ||||||||||||
Charges assessed to policyholders |
— | — | (646 | ) | — | (646 | ) | |||||||||||||
Acquisition costs deferred |
— | — | (3 | ) | — | (3 | ) | |||||||||||||
Amortization of deferred acquisition costs and intangibles |
— | — | 463 | — | 463 | |||||||||||||||
Deferred income taxes |
(1 | ) | 212 | 17 | — | 228 | ||||||||||||||
Derivative instruments, limited partnerships and other |
— | (70 | ) | (42 | ) | — | (112 | ) | ||||||||||||
Stock-based compensation expense |
39 | — | — | — | 39 | |||||||||||||||
Change in certain assets and liabilities: |
||||||||||||||||||||
Accrued investment income and other assets |
2 | 16 | (105 | ) | (5 | ) | (92 | ) | ||||||||||||
Insurance reserves |
— | — | 1,217 | — | 1,217 | |||||||||||||||
Current tax liabilities |
(1 | ) | 41 | (34 | ) | — | 6 | |||||||||||||
Other liabilities, policy and contract claims and other policy-related balances |
11 | 30 | 784 | 5 | 830 | |||||||||||||||
Cash from (used by) operating activities—discontinued operations |
— | (258 | ) | 239 | — | (19 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash from operating activities |
17 | 282 | 1,661 | — | 1,960 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash flows from (used by) investing activities: |
||||||||||||||||||||
Proceeds from maturities and repayments of investments: |
||||||||||||||||||||
Fixed maturity securities |
— | — | 3,637 | — | 3,637 | |||||||||||||||
Commercial mortgage loans |
— | — | 744 | — | 744 | |||||||||||||||
Other invested assets |
— | — | 182 | — | 182 | |||||||||||||||
Proceeds from sales of investments: |
||||||||||||||||||||
Fixed maturity and equity securities |
— | — | 3,040 | — | 3,040 | |||||||||||||||
Purchases and originations of investments: |
||||||||||||||||||||
Fixed maturity and equity securities |
— | — | (7,763 | ) | — | (7,763 | ) | |||||||||||||
Commercial mortgage loans |
— | — | (547 | ) | — | (547 | ) | |||||||||||||
Other invested assets |
— | — | (449 | ) | — | (449 | ) | |||||||||||||
Short-term investments, net |
— | 45 | (10 | ) | — | 35 | ||||||||||||||
Policy loans, net |
— | — | 190 | — | 190 | |||||||||||||||
Intercompany notes receivable |
(10 | ) | (16 | ) | 200 | (174 | ) | — | ||||||||||||
Capital contributions to subsidiaries |
(2 | ) | — | 2 | — | — | ||||||||||||||
Cash used by investing activities—discontinued operations |
— | — | (222 | ) | — | (222 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash from (used by) investing activities |
(12 | ) | 29 | (996 | ) | (174 | ) | (1,153 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash flows used by financing activities: |
||||||||||||||||||||
Deposits to universal life and investment contracts |
— | — | 862 | — | 862 | |||||||||||||||
Withdrawals from universal life and investment contracts |
— | — | (2,282 | ) | — | (2,282 | ) | |||||||||||||
Redemption of non-recourse funding obligations |
— | — | (315 | ) | — | (315 | ) | |||||||||||||
Proceeds from the issuance of long-term debt |
— | — | 738 | — | 738 | |||||||||||||||
Repayment and repurchase of long-term debt |
— | (490 | ) | — | — | (490 | ) | |||||||||||||
Intercompany notes payable |
— | (190 | ) | 16 | 174 | — | ||||||||||||||
Other, net |
(5 | ) | (14 | ) | 17 | — | (2 | ) | ||||||||||||
Cash used by financing activities—discontinued operations |
— | — | (18 | ) | — | (18 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash used by financing activities |
(5 | ) | (694 | ) | (982 | ) | 174 | (1,507 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $18 related to discontinued operations) |
— | — | 15 | — | 15 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net change in cash, cash equivalents and restricted cash |
— | (383 | ) | (302 | ) | — | (685 | ) | ||||||||||||
Cash, cash equivalents and restricted cash at beginning of period |
— | 1,461 | 1,880 | — | 3,341 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash, cash equivalents and restricted cash at end of period |
— | 1,078 | 1,578 | — | 2,656 | |||||||||||||||
Less cash, cash equivalents and restricted cash of discontinued operations at end of period |
— | — | 95 | — | 95 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash, cash equivalents and restricted cash of continuing operations at end of period |
$ | — | $ | 1,078 | $ | 1,483 | $ | — | $ | 2,561 | ||||||||||
|
|
|
|
|
|
|
|
|
|
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk |
Item 4. |
Controls and Procedures |
Item 1. |
Legal Proceedings |
Item 1A. |
Risk Factors |
Item 6. |
Exhibits |
GENWORTH FINANCIAL, INC. (Registrant) | ||||
Date: May 5, 2021 |
||||
By: | /s/ Matthew D. Farney | |||
Matthew D. Farney Vice President and Controller (Principal Accounting Officer) |